| 1 | 0,25 MG RPC1063 | - | - | - | - | 1件: 96 96 💬
|
| 2 | 0.25 MG RPC1063 | - | - | - | - | 3件: 13 13, 96, 97 💬
|
| 3 | 0114-0006B | - | - | - | - | 2件: 46 46, 96 💬
|
| 4 | 10 MG | - | - | - | - | 1件: 96 96 💬
|
| 5 | 100 MG | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
| 6 | 100% pomegranate juice | - | - | - | - | 2件: 96 96, 97 💬
|
| 7 | 1000 IU D3 | - | - | - | - | 1件: 96 96 💬
|
| 8 | 18F-FDG and 68GA-fapi PET/CT | 1件: Fludeoxyglucose (18F) Fludeoxyglucose (18F) | 1件: Fludeoxyglucose F 18
Fludeoxyglucose F 18
💬
| - | - | 1件: 96 96 💬
|
| 9 | 1MG RPC1063 | - | - | - | - | 1件: 96 96 💬
|
| 10 | 2'-fucosyllactose | - | - | - | - | 2件: 96 96, 97 💬
|
| 11 | 23-valent polysaccharide pneumococcal vaccine | - | - | - | - | 2件: 96 96, 97 💬
|
| 12 | 25 MG ontamalimab | - | - | - | - | 2件: 96 96, 97 💬
|
| 13 | 331731-18-1 | - | - | - | - | 5件: 46 46, 96, 97, 107, 271 💬
|
| 14 | 4-aminosalicylic acid | - | - | - | - | 1件: 96 96 💬
|
| 15 | 4-aminosalicylic acid extended release granules | - | - | - | - | 1件: 96 96 💬
|
| 16 | 40 MG | - | - | - | - | 1件: 96 96 💬
|
| 17 | 40 MG MSB11022 | - | - | - | - | 5件: 46 46, 96, 97, 107, 271 💬
|
| 18 | 5-aminolevulinic acid | - | - | - | - | 1件: 96 96 💬
|
| 19 | 5-aminosalicyl acid | - | - | - | - | 1件: 96 96 💬
|
| 20 | 5-aminosalicylic acid | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 2件: 96 96, 97 💬
|
| 21 | 5-HTP | - | - | - | - | 2件: 96 96, 97 💬
|
| 22 | 5000 IU D3 | - | - | - | - | 1件: 96 96 💬
|
| 23 | 549-0261/F02-01 | - | - | - | - | 2件: 96 96, 97 💬
|
| 24 | 6 mercaptopurine | - | - | - | - | 2件: 96 96, 97 💬
|
| 25 | 6-[(methyl-4-nitro-1H-imidazol-5-YL)thio]-1H-purine | - | - | - | - | 1件: 96 96 💬
|
| 26 | 6-mercaptopurine | 1件: Mercaptopurine Mercaptopurine | 2件: Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| 1件: hprT hprT 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 3件: 96 96, 97, 164 💬
|
| 27 | 6-MP | 1件: Mercaptopurine Mercaptopurine | 2件: Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| 1件: hprT hprT 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 2件: 96 96, 97 💬
|
| 28 | 75 MG ontamalimab | - | - | - | - | 2件: 96 96, 97 💬
|
| 29 | 80 MG DR-6MP | - | - | - | - | 1件: 96 96 💬
|
| 30 | 99MTC-S-hynic certolizumab pegol | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 96 💬
|
| 31 | A fixed-dose combination OF 95 MG clarithromycin, 45 MG rifabutin, and 10 MG clofazimine | - | - | - | - | 1件: 96 96 💬
|
| 32 | A-1293543.74 | - | - | - | - | 1件: 96 96 💬
|
| 33 | AB1010 | - | - | - | - | 6件: 2 2, 5, 6, 13, 46, 96 💬
|
| 34 | Abatacept | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 26件: 2 2, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
|
| 35 | ABBV-066 | - | - | - | - | 2件: 96 96, 97 💬
|
| 36 | ABBV-154 | - | - | - | - | 2件: 46 46, 96 💬
|
| 37 | ABBV-382 | - | - | - | - | 1件: 96 96 💬
|
| 38 | Abbvie care 2.0 | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
| 39 | ABR-215062 sodium salt | - | - | - | - | 2件: 13 13, 96 💬
|
| 40 | Abrilumab | 1件: Abrilumab Abrilumab | 1件: Abrilumab
Abrilumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 💬
|
| 41 | ABT 494 12MG | - | - | - | - | 2件: 46 46, 96 💬
|
| 42 | ABT 494 3MG | - | - | - | - | 2件: 46 46, 96 💬
|
| 43 | ABT humira | - | - | - | - | 1件: 96 96 💬
|
| 44 | ABT-494 | - | - | - | - | 7件: 41 41, 46, 49, 96, 97, 107, 271 💬
|
| 45 | ABT-874 | - | - | - | - | 1件: 96 96 💬
|
| 46 | ABX464 | - | - | - | - | 3件: 46 46, 96, 97 💬
|
| 47 | Accelerated 1 HOUR-infusion | - | - | - | - | 2件: 96 96, 97 💬
|
| 48 | Accelerated 30 minutes-infusion | - | - | - | - | 2件: 96 96, 97 💬
|
| 49 | Acded + modulen | - | - | - | - | 1件: 96 96 💬
|
| 50 | Acetaminophen | 1件: Acetaminophen Acetaminophen | 1件: Acetaminophen
Acetaminophen
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 14件: 11 11, 19, 34, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
|
| 51 | Active comparator | - | - | - | - | 5件: 6 6, 43, 44, 46, 96 💬
|
| 52 | Adalimumab | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 18件: 19 19, 37, 40, 41, 46, 55, 56, 84, 96, 97, 107, 160, 164, 222, 226, 269, 270, 271 💬
|
| 53 | Adalimumab 40 MG EOW or EW | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 54 | Adalimumab and infliximab | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 55 | Adalimumab injection | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 5件: 38 38, 40, 46, 96, 162 💬
|
| 56 | Adalimumab PRN | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 57 | Adalimumab-680LT | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 58 | Admsc | 1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins | - | - | - | 2件: 51 51, 96 💬
|
| 59 | Adrenomedullin | 1件: Adrenomedullin Adrenomedullin | - | - | - | 3件: 96 96, 97, 124 💬
|
| 60 | Adsvf | - | - | - | - | 2件: 15 15, 96 💬
|
| 61 | Adult human mesenchymal stem cells | 1件: Remestemcel-L Remestemcel-L | 1件: Remestemcel-L
Remestemcel-L
💬
| - | - | 2件: 85 85, 96 💬
|
| 62 | Advancement plasty | - | - | - | - | 1件: 96 96 💬
|
| 63 | AERO-RED 100 MG/ML gotas orales EN solucióN | - | - | - | - | 2件: 96 96, 97 💬
|
| 64 | After surgery FOR crohn'S disease, eligible patients will BE randomized 1:1 TO receive oral EXL01 | - | - | - | - | 1件: 96 96 💬
|
| 65 | AGMB-129 | - | - | - | - | 1件: 96 96 💬
|
| 66 | AIN457 | - | - | - | - | 9件: 13 13, 37, 41, 46, 56, 96, 97, 107, 271 💬
|
| 67 | Albendazole | 1件: Albendazole Albendazole | 1件: Albendazole
Albendazole
💬
| - | - | 1件: 96 96 💬
|
| 68 | Albumine humaine | - | - | - | - | 1件: 96 96 💬
|
| 69 | Aldesleukin | 1件: Aldesleukin Aldesleukin | 1件: Aldesleukin
Aldesleukin
💬
| 3件: IL2RA IL2RA, IL2RB, IL2RG 💬
| 14件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | 5件: 2 2, 49, 65, 96, 97 💬
|
| 70 | Alemtuzumab | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 18件: 13 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 65, 85, 96, 107, 283, 284, 285, 326 💬
|
| 71 | Alequel | - | - | - | - | 2件: 96 96, 97 💬
|
| 72 | Alfacalcidol | 1件: Alfacalcidol Alfacalcidol | 1件: Alfacalcidol
Alfacalcidol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 7件: 41 41, 46, 50, 96, 107, 235, 238 💬
|
| 73 | Alicaforsen | 1件: Alicaforsen Alicaforsen | 1件: Alicaforsen sodium
Alicaforsen sodium
💬
| 1件: ICAM1 ICAM1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Cell adhesion molecules, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, Human T-cell leukemia virus 1 infection, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Staphylococcus aureus infection, TNF signaling pathway, Viral myocarditis 💬 | 2件: 96 96, 97 💬
|
| 74 | ALLO-ASC | - | - | - | - | 1件: 96 96 💬
|
| 75 | ALLO-ASC-CD | - | - | - | - | 1件: 96 96 💬
|
| 76 | Allogeneic adipose tissue-derived mesenchymal stem cells expanded | - | - | - | - | 3件: 38 38, 96, 162 💬
|
| 77 | Allogeneic bone marrow derived human mesenchymal stem cells | 1件: Allogenic bone marrow-derived mesenchymal stem cells Allogenic bone marrow-derived mesenchymal stem cells | - | - | - | 1件: 96 96 💬
|
| 78 | Allogeneic bone marrow transplantation | - | - | - | - | 8件: 60 60, 62, 65, 96, 164, 284, 285, 286 💬
|
| 79 | Allogeneic stem cell therapy | - | - | - | - | 1件: 96 96 💬
|
| 80 | Allogenic eascs 5 milion cells/ML suspension FOR injection. CX601 | - | - | - | - | 1件: 96 96 💬
|
| 81 | Allogenic eascs 5 million cells/ML suspension FOR injection CX601 | - | - | - | - | 1件: 96 96 💬
|
| 82 | Allogenic eascs 5 million cells/ML suspension FOR injection. CX601 | - | - | - | - | 1件: 96 96 💬
|
| 83 | Allogenic mesenchymal stem cell isolated from adipose tissue | - | - | - | - | 3件: 38 38, 96, 162 💬
|
| 84 | Allopurinol | 1件: Allopurinol Allopurinol | 2件: Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| 1件: XDH XDH 💬
| 4件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | 7件: 6 6, 46, 57, 60, 66, 96, 97 💬
|
| 85 | Allopurinol sandoz 100 MG, tabletten | 1件: Allopurinol Allopurinol | 2件: Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| 1件: XDH XDH 💬
| 4件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | 1件: 96 96 💬
|
| 86 | Allopurinol sodium | 1件: Allopurinol Allopurinol | 2件: Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| 1件: XDH XDH 💬
| 4件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | 2件: 96 96, 97 💬
|
| 87 | Alofisel | 1件: Darvadstrocel Darvadstrocel | 1件: Darvadstrocel
Darvadstrocel
💬
| - | - | 1件: 96 96 💬
|
| 88 | Also referred TO AS MED2070 | - | - | - | - | 1件: 96 96 💬
|
| 89 | Also referred TO AS MEDI2070 | - | - | - | - | 2件: 96 96, 97 💬
|
| 90 | ALX-0600 | - | - | - | - | 1件: 96 96 💬
|
| 91 | AMG 139 | - | - | - | - | 1件: 96 96 💬
|
| 92 | AMG 181 | - | - | - | - | 2件: 96 96, 97 💬
|
| 93 | AMG 827 | - | - | - | - | 2件: 46 46, 96 💬
|
| 94 | AMG 827 210 MG | - | - | - | - | 2件: 46 46, 96 💬
|
| 95 | AMG 827 350 MG | - | - | - | - | 1件: 96 96 💬
|
| 96 | AMG 827 700 MG | - | - | - | - | 1件: 96 96 💬
|
| 97 | Amgevita | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 98 | Amgevita 40 MG injektionslösung IM fertigpen | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 99 | Amgevita 40 MG injektionslösung IN einer fertigspritze | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 100 | Amgevita 40MG solution FOR injection | - | - | - | - | 2件: 96 96, 97 💬
|
| 101 | Aminosalicylic acid | 1件: Aminosalicylic acid Aminosalicylic acid | 1件: Aminosalicylic acid
Aminosalicylic acid
💬
| - | - | 2件: 96 96, 97 💬
|
| 102 | Amoxicillin | 2件: Amoxicillin Amoxicillin, Clavulanic acid | 5件: Amoxicillin
Amoxicillin
,
Clavulanate potassium
,
Amoxicillin sodium
,
Amoxicillin
,
Clavulanic acid
💬
| - | - | 5件: 46 46, 63, 96, 97, 299 💬
|
| 103 | AN100226 | - | - | - | - | 2件: 13 13, 96 💬
|
| 104 | Andecaliximab | 1件: Andecaliximab Andecaliximab | 1件: Andecaliximab
Andecaliximab
💬
| 1件: MMP9 MMP9 💬
| 15件: Bladder cancer Bladder cancer, Diabetic cardiomyopathy, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Hepatitis B, IL-17 signaling pathway, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Relaxin signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬 | 5件: 46 46, 96, 97, 272, 299 💬
|
| 105 | Andosan | - | - | - | - | 2件: 96 96, 97 💬
|
| 106 | Anti TNF | - | - | - | - | 1件: 96 96 💬
|
| 107 | Anti TNF humanized antibody FAB fragment-PEG conjugate | - | - | - | - | 1件: 96 96 💬
|
| 108 | Anti TNF therapy including infliximab | - | - | - | - | 2件: 96 96, 97 💬
|
| 109 | ANTI-CD3 | 1件: Muromonab Muromonab | 1件: Muromonab-CD3
Muromonab-CD3
💬
| 3件: CD3D CD3D, CD3E, CD3G 💬
| 11件: Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 96 96 💬
|
| 110 | ANTI-CD3 monoclonal antibody | 1件: Muromonab Muromonab | 1件: Muromonab-CD3
Muromonab-CD3
💬
| 3件: CD3D CD3D, CD3E, CD3G 💬
| 11件: Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 2件: 96 96, 97 💬
|
| 111 | ANTI-IL-23 monoclonal antibody | - | - | - | - | 1件: 96 96 💬
|
| 112 | ANTI-IL-6 MAB | - | - | - | - | 2件: 46 46, 96 💬
|
| 113 | ANTI-IL12/23 or ANTI-IL23 - risankizumab | - | - | - | - | 1件: 96 96 💬
|
| 114 | ANTI-IL12/23 or ANTI-IL23 - ustekinumab | - | - | - | - | 1件: 96 96 💬
|
| 115 | ANTI-integrin - vedolizumab IV and SC | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 1件: 96 96 💬
|
| 116 | ANTI-interferon-gamma monoclonal antibody | - | - | - | - | 1件: 96 96 💬
|
| 117 | ANTI-interleukin-23 immunoglobulin G2 (IGG2) human monoclonal antibody | - | - | - | - | 2件: 96 96, 97 💬
|
| 118 | ANTI-interleukin-6 monoclonal antibody | - | - | - | - | 2件: 46 46, 96 💬
|
| 119 | ANTI-madcam antibody | - | - | - | - | 2件: 96 96, 97 💬
|
| 120 | ANTI-TNF | - | - | - | - | 5件: 46 46, 96, 97, 107, 271 💬
|
| 121 | ANTI-TNF discontinuation: physiological saline solution | - | - | - | - | 2件: 96 96, 97 💬
|
| 122 | ANTI-TNF drug | - | - | - | - | 2件: 96 96, 97 💬
|
| 123 | ANTI-TNF therapy | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
| 124 | ANTI-tumour necrosis factor A antibodies | - | - | - | - | 1件: 96 96 💬
|
| 125 | Antibiotics | - | - | - | - | 2件: 96 96, 97 💬
|
| 126 | Anticorpo monoclonale anti IL-23 | - | - | - | - | 1件: 96 96 💬
|
| 127 | Anticorpo monoclonale ANTI-IL-23 | - | - | - | - | 1件: 96 96 💬
|
| 128 | Antithymocyte immunoglobulin | 1件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | 1件: Anti-human thymocyte immunoglobulin, rabbit
Anti-human thymocyte immunoglobulin, rabbit
💬
| 11件: CD2 CD2, CD3D, CD3E, CD3G, CD4, CD5, CD7, CD8A, CD8B, IL2RA, ITGAL 💬
| 31件: Antigen processing and presentation Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬 | 2件: 13 13, 96 💬
|
| 129 | APD334 | - | - | - | - | 5件: 93 93, 96, 97, 98, 269 💬
|
| 130 | APD371 | - | - | - | - | 1件: 96 96 💬
|
| 131 | Apheresis catheter placement | - | - | - | - | 1件: 96 96 💬
|
| 132 | Apixaban 2.5 milligram | 1件: Apixaban Apixaban | 1件: Apixaban
Apixaban
💬
| 1件: F10 F10 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 2件: 96 96, 97 💬
|
| 133 | Application OF adalimumab | - | - | - | - | 1件: 96 96 💬
|
| 134 | AR401959 L-arginine | - | - | - | - | 3件: 96 96, 97, 98 💬
|
| 135 | Artesunate | 1件: Artesunate Artesunate | 1件: Artesunate
Artesunate
💬
| - | - | 4件: 18 18, 66, 86, 96 💬
|
| 136 | Ascs: adipose derived stem cells | - | - | - | - | 1件: 96 96 💬
|
| 137 | Aspirin 81MG EC TAB | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: Aspirin
Aspirin
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 138 | AST-120 | - | - | - | - | 2件: 96 96, 97 💬
|
| 139 | ATG | - | - | - | - | 6件: 13 13, 19, 60, 96, 222, 285 💬
|
| 140 | ATH-063 | - | - | - | - | 2件: 96 96, 97 💬
|
| 141 | Atorvastatin | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 17件: 13 13, 22, 46, 49, 51, 58, 79, 84, 88, 93, 96, 97, 160, 225, 271, 297, 299 💬
|
| 142 | Autologous adipose derived stromal vascular fraction | - | - | - | - | 1件: 96 96 💬
|
| 143 | Autologous CD34-selected peripheral blood stem cells transplant | - | - | - | - | 1件: 96 96 💬
|
| 144 | Autologous mesenchymal stromal cell | - | - | - | - | 2件: 96 96, 298 💬
|
| 145 | Autologous ovalbumin-specific type 1 regulatory T lymphocytes expanded population | - | - | - | - | 1件: 96 96 💬
|
| 146 | Autologous stem cell transplant | - | - | - | - | 4件: 28 28, 53, 56, 96 💬
|
| 147 | Autologous stem cell transplantation | - | - | - | - | 4件: 13 13, 28, 56, 96 💬
|
| 148 | AVB-114 | - | - | - | - | 1件: 96 96 💬
|
| 149 | AZA | - | - | - | - | 4件: 11 11, 40, 96, 97 💬
|
| 150 | AZA capsules | - | - | - | - | 1件: 96 96 💬
|
| 151 | Azathioprin | - | - | - | - | 3件: 46 46, 54, 96 💬
|
| 152 | Azathioprin-ratiopharm 25 MG | - | - | - | - | 1件: 96 96 💬
|
| 153 | Azathioprine | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 22件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 63, 65, 66, 84, 85, 94, 95, 96, 97, 162 💬
|
| 154 | Azathioprine (AZA) caps | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
| 155 | Azathioprine + infliximab | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
| 156 | Azathioprine - ratiopharm 50 MG | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
| 157 | Azathioprine / 6 mercaptopurine | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
| 158 | Azathioprine IN case OF endoscopic recurrence | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
| 159 | Azathioprine individualised dose | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
| 160 | Azathioprine or adalimumab and infliximab | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
| 161 | Azathioprine or mesalazine | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
| 162 | Azathioprine or methotrexate | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
| 163 | Azathioprine weight-based dose | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
| 164 | Azathioprine+enteral nutrition | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
| 165 | Azatioprina | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 2件: 96 96, 97 💬
|
| 166 | Azatioprina aspen - 50 compresse | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
| 167 | AZD7798 | - | - | - | - | 1件: 96 96 💬
|
| 168 | AZD9056 | - | - | - | - | 2件: 46 46, 96 💬
|
| 169 | Azithromycin | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 6件: 13 13, 84, 85, 96, 228, 299 💬
|
| 170 | Azithromycin + metronidazole | 2件: Azithromycin Azithromycin, Metronidazole | 5件: Metronidazole
Metronidazole
,
Azithromycin hydrate
,
Metronidazole hydrochloride
,
Azithromycin
,
Azithromycin
💬
| - | - | 1件: 96 96 💬
|
| 171 | Azithromycin pill | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 1件: 96 96 💬
|
| 172 | B. theta | - | - | - | - | 1件: 96 96 💬
|
| 173 | Bacteriophage preparation | - | - | - | - | 1件: 96 96 💬
|
| 174 | Bacteriotherapy | - | - | - | - | 2件: 96 96, 97 💬
|
| 175 | Bacteroides thetaiotaomicron | 1件: Bacteroides thetaiotaomicron Bacteroides thetaiotaomicron | - | - | - | 1件: 96 96 💬
|
| 176 | Beta carotene from dunaliella algae | 1件: Beta carotene Beta carotene | 1件: beta Carotene
beta Carotene
💬
| - | - | 1件: 96 96 💬
|
| 177 | Betamethasone | 1件: Betamethasone Betamethasone | 6件: Betamethasone
Betamethasone
,
Betamethasone sodium phosphate
,
Betamethasone valerate
,
Betamethasone acetate
,
Betamethasone dipropionate
,
Betamethasone benzoate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 5件: 28 28, 83, 90, 96, 235 💬
|
| 178 | Bezlotoxumab | 1件: Bezlotoxumab Bezlotoxumab | 1件: Bezlotoxumab
Bezlotoxumab
💬
| - | - | 2件: 96 96, 97 💬
|
| 179 | BI 655066 | - | - | - | - | 1件: 96 96 💬
|
| 180 | BI 655066 10 MG/ML | - | - | - | - | 1件: 96 96 💬
|
| 181 | BI 655066 90 MG/ML | - | - | - | - | 2件: 96 96, 271 💬
|
| 182 | BI 655130 | - | - | - | - | 3件: 37 37, 96, 97 💬
|
| 183 | BI 695501 | - | - | - | - | 2件: 46 46, 96 💬
|
| 184 | BI 706321 | - | - | - | - | 1件: 96 96 💬
|
| 185 | BI-peglyte | - | - | - | - | 2件: 96 96, 97 💬
|
| 186 | BI706321 | - | - | - | - | 1件: 96 96 💬
|
| 187 | Bibr 796 BS, 20 MG | - | - | - | - | 1件: 96 96 💬
|
| 188 | Bibr 796 BS, 5 MG | - | - | - | - | 1件: 96 96 💬
|
| 189 | BIF195 capsules | - | - | - | - | 1件: 96 96 💬
|
| 190 | Bifidobacterium | 1件: Bifidobacterium spp. Bifidobacterium spp. | 1件: Bifidobacterium
Bifidobacterium
💬
| - | - | 6件: 6 6, 35, 67, 96, 97, 271 💬
|
| 191 | Bifidobacterium infantis 35624 | 2件: Bifidobacterium longum infantis Bifidobacterium longum infantis, Bifidobacterium spp. | 1件: Bifidobacterium
Bifidobacterium
💬
| - | - | 2件: 96 96, 97 💬
|
| 192 | Biological agents | - | - | - | - | 2件: 46 46, 96 💬
|
| 193 | Biological drug | - | - | - | - | 4件: 46 46, 96, 97, 107 💬
|
| 194 | Biological samplings | - | - | - | - | 1件: 96 96 💬
|
| 195 | Biologics | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
| 196 | Biosimilar | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
| 197 | Biosimilar infliximab | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 46 46, 96, 97 💬
|
| 198 | Biospecimen collection | - | - | - | - | 18件: 13 13, 26, 28, 34, 46, 49, 50, 51, 53, 60, 62, 65, 96, 97, 159, 284, 285, 286 💬
|
| 199 | Bleomycin | 1件: Bleomycin Bleomycin | 3件: Bleomycin sulfate
Bleomycin sulfate
,
Bleomycin hydrochloride
,
Bleomycin
💬
| - | - | 3件: 96 96, 278, 280 💬
|
| 200 | BLI-1300 high dose | - | - | - | - | 1件: 96 96 💬
|
| 201 | BLI-1300 LOW dose | - | - | - | - | 1件: 96 96 💬
|
| 202 | Blood and fecal samples | - | - | - | - | 2件: 96 96, 97 💬
|
| 203 | Blood and stools samples | - | - | - | - | 1件: 96 96 💬
|
| 204 | Blood draw | - | - | - | - | 7件: 6 6, 19, 65, 67, 96, 231, 299 💬
|
| 205 | Blood or saliva sample collection | - | - | - | - | 3件: 96 96, 97, 299 💬
|
| 206 | Blood sample | - | - | - | - | 28件: 2 2, 3, 8, 13, 34, 46, 49, 51, 53, 61, 65, 66, 67, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 280, 288, 294, 299 💬
|
| 207 | Blood samples | - | - | - | - | 12件: 13 13, 41, 46, 51, 61, 96, 97, 167, 227, 240, 271, 280 💬
|
| 208 | Blood sampling | - | - | - | - | 9件: 13 13, 17, 46, 49, 51, 96, 98, 106, 162 💬
|
| 209 | Blood sampling from infant | - | - | - | - | 3件: 46 46, 96, 271 💬
|
| 210 | Blood sampling from mother | - | - | - | - | 3件: 46 46, 96, 271 💬
|
| 211 | Blood sampling from umbilical cord | - | - | - | - | 3件: 46 46, 96, 271 💬
|
| 212 | Blue light photopheresis | - | - | - | - | 1件: 96 96 💬
|
| 213 | Blueberry-rich diet | 1件: Blueberry Blueberry | - | - | - | 2件: 96 96, 97 💬
|
| 214 | BMS-188667 | - | - | - | - | 10件: 46 46, 49, 53, 65, 96, 97, 107, 160, 222, 271 💬
|
| 215 | BMS-936557 | - | - | - | - | 2件: 96 96, 97 💬
|
| 216 | BMS-945429 | 1件: Clazakizumab Clazakizumab | 1件: Clazakizumab
Clazakizumab
💬
| - | - | 2件: 46 46, 96 💬
|
| 217 | BMS-986165 | - | - | - | - | 3件: 49 49, 96, 97 💬
|
| 218 | BMS986165 | - | - | - | - | 2件: 96 96, 97 💬
|
| 219 | Boulardii | - | - | - | - | 2件: 96 96, 97 💬
|
| 220 | Brazikumab | 1件: Brazikumab Brazikumab | 1件: Brazikumab
Brazikumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
| 221 | Brazikumab high dose | 1件: Brazikumab Brazikumab | 1件: Brazikumab
Brazikumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 96 96 💬
|
| 222 | Brazikumab induction dose | 1件: Brazikumab Brazikumab | 1件: Brazikumab
Brazikumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
| 223 | Brazikumab IV infusion | 1件: Brazikumab Brazikumab | 1件: Brazikumab
Brazikumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 96 96 💬
|
| 224 | Brazikumab LOW dose | 1件: Brazikumab Brazikumab | 1件: Brazikumab
Brazikumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 96 96 💬
|
| 225 | Brazikumab maintenance dose | 1件: Brazikumab Brazikumab | 1件: Brazikumab
Brazikumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
| 226 | Brazikumab SC injection | 1件: Brazikumab Brazikumab | 1件: Brazikumab
Brazikumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 96 96 💬
|
| 227 | Breast milk sampling | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
| 228 | Brepocitinib 25 MG | - | - | - | - | 2件: 96 96, 97 💬
|
| 229 | Brepocitinib 5 MG | - | - | - | - | 2件: 96 96, 97 💬
|
| 230 | Brepocitinib 5MG | - | - | - | - | 1件: 96 96 💬
|
| 231 | BT-11 | - | - | - | - | 2件: 96 96, 97 💬
|
| 232 | BT-11 1000MG | - | - | - | - | 2件: 96 96, 97 💬
|
| 233 | BT-11 500 MG | - | - | - | - | 2件: 96 96, 97 💬
|
| 234 | BT-11 880 MG | - | - | - | - | 1件: 96 96 💬
|
| 235 | Budenofalk | - | - | - | - | 1件: 96 96 💬
|
| 236 | Budenofalk 3MG gastro-resistant capsules | - | - | - | - | 1件: 96 96 💬
|
| 237 | Budenofalk 9MG gastro-resistant granules | - | - | - | - | 1件: 96 96 💬
|
| 238 | Budesonide | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 7件: 66 66, 93, 94, 95, 96, 97, 98 💬
|
| 239 | Budezonide | - | - | - | - | 1件: 96 96 💬
|
| 240 | Bupivacaine/epinephrine/dexamethasone | 1件: Bupivacaine Bupivacaine | 2件: Bupivacaine hydrochloride
Bupivacaine hydrochloride
,
Bupivacaine
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 96 96 💬
|
| 241 | Bupropion | 1件: Bupropion Bupropion | 3件: Bupropion hydrochloride
Bupropion hydrochloride
,
Bupropion
,
Bupropion hydrobromide
💬
| 2件: SLC6A2 SLC6A2, SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 3件: 8 8, 21, 96 💬
|
| 242 | BY demand | - | - | - | - | 2件: 96 96, 97 💬
|
| 243 | C326, IL-6 inhibitory avimer protein | 1件: C326 C326 | - | - | - | 1件: 96 96 💬
|
| 244 | Caffeine | 1件: Caffeine Caffeine | 3件: Caffeine
Caffeine
,
Caffeine hydrate
,
Caffeine citrate
💬
| 11件: ADORA1 ADORA1, ADORA2A, PDE1, PDE2A, PDE3A, PDE3B, PDE4, PDE4, PDE4, PDE4, PDE5 💬
| 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 2 2, 6, 13, 21, 46, 96, 97, 265 💬
|
| 245 | Caffeine 100 MG | 1件: Caffeine Caffeine | 3件: Caffeine
Caffeine
,
Caffeine hydrate
,
Caffeine citrate
💬
| 11件: ADORA1 ADORA1, ADORA2A, PDE1, PDE2A, PDE3A, PDE3B, PDE4, PDE4, PDE4, PDE4, PDE5 💬
| 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 246 | Calcio | 1件: Calcium Calcium | - | - | - | 3件: 13 13, 96, 97 💬
|
| 247 | Calcitriol | 1件: Calcitriol Calcitriol | 1件: Calcitriol
Calcitriol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 8件: 18 18, 37, 46, 49, 66, 96, 235, 326 💬
|
| 248 | Calcium carbonate | 2件: Calcium Calcium, Calcium carbonate | 2件: Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | 7件: 13 13, 19, 46, 75, 96, 235, 299 💬
|
| 249 | Caltrate pill | - | - | - | - | 1件: 96 96 💬
|
| 250 | Cannabidiol | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 18件: 6 6, 8, 13, 19, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 271 💬
|
| 251 | Cannabidiol , synthetic form | 1件: Cannabidiol Cannabidiol | 1件: Cannabidiol
Cannabidiol
💬
| 2件: CNR1 CNR1, CNR2 💬
| 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 96 96 💬
|
| 252 | Cannabis, medical | 1件: Medical Cannabis Medical Cannabis | 1件: Cannabis
Cannabis
💬
| - | - | 5件: 2 2, 6, 13, 96, 97 💬
|
| 253 | Capsule endoscopy | - | - | - | - | 1件: 96 96 💬
|
| 254 | CC-5013 | - | - | - | - | 2件: 28 28, 96 💬
|
| 255 | CCX282-B | - | - | - | - | 1件: 96 96 💬
|
| 256 | CD-C-food | - | - | - | - | 1件: 96 96 💬
|
| 257 | CD7 CAR T-cells | - | - | - | - | 3件: 50 50, 96, 97 💬
|
| 258 | Cded (crohn'S disease exclusion diet) IN addition TO ANTI-TNF therapy | - | - | - | - | 2件: 96 96, 97 💬
|
| 259 | Cded+dairy | - | - | - | - | 1件: 96 96 💬
|
| 260 | Cded+PEN | - | - | - | - | 1件: 96 96 💬
|
| 261 | CDP6038 | - | - | - | - | 2件: 46 46, 96 💬
|
| 262 | CDP870 | - | - | - | - | 3件: 46 46, 96, 271 💬
|
| 263 | Celebrex | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 4件: 46 46, 96, 107, 271 💬
|
| 264 | Celecoxib | 1件: Celecoxib Celecoxib | 1件: Celecoxib
Celecoxib
💬
| 1件: PTGS2 PTGS2 💬
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 13件: 2 2, 3, 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
|
| 265 | Certican | 1件: Everolimus Everolimus | 1件: Everolimus
Everolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 3件: 67 67, 96, 228 💬
|
| 266 | Certolizumab | - | - | - | - | 4件: 46 46, 96, 270, 271 💬
|
| 267 | Certolizumab pegol | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 7件: 37 37, 46, 49, 96, 107, 226, 271 💬
|
| 268 | Certolizumab pegol /cimzia | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 269 | Certolizumab pegol 400 MG | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 270 | Chadox2 HAV | - | - | - | - | 1件: 96 96 💬
|
| 271 | Chenodeoxycholic acid | 1件: Chenodeoxycholic acid Chenodeoxycholic acid | 1件: Chenodiol
Chenodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 4件: 20 20, 96, 234, 263 💬
|
| 272 | Chenodiol | 1件: Chenodeoxycholic acid Chenodeoxycholic acid | 1件: Chenodiol
Chenodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 1件: 96 96 💬
|
| 273 | Chenofalk | - | - | - | - | 1件: 96 96 💬
|
| 274 | Chimeric IGG1 monoclonal antibody | - | - | - | - | 1件: 96 96 💬
|
| 275 | Chlorure DE sodium | - | - | - | - | 1件: 96 96 💬
|
| 276 | Cholecalciferol | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 9件: 13 13, 19, 34, 46, 49, 96, 97, 298, 299 💬
|
| 277 | Cholecalciferol 10,000 IU | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 96 96 💬
|
| 278 | Cholecalciferol 400 IU | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 96 96 💬
|
| 279 | Cholecalciferol concentrate | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 96 96 💬
|
| 280 | Cholestagel | 1件: Colesevelam Colesevelam | 2件: Colesevelam hydrochloride
Colesevelam hydrochloride
,
Colesevelam
💬
| - | - | 2件: 79 79, 96 💬
|
| 281 | Chondroitin sulfate | 1件: Chondroitin sulfate Chondroitin sulfate | 1件: Chondroitin sulfate A
Chondroitin sulfate A
💬
| - | - | 1件: 96 96 💬
|
| 282 | Cimzia | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 6件: 46 46, 49, 96, 97, 107, 271 💬
|
| 283 | Cimzia 200 MG solution FOR injection | 1件: Certolizumab pegol Certolizumab pegol | 1件: Certolizumab pegol
Certolizumab pegol
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 46 46, 96, 271 💬
|
| 284 | Ciprofloxacin | 1件: Ciprofloxacin Ciprofloxacin | 3件: Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | 6件: 2 2, 46, 60, 96, 97, 299 💬
|
| 285 | Ciprofloxacin hydrochloride | 1件: Ciprofloxacin Ciprofloxacin | 3件: Ciprofloxacin
Ciprofloxacin
,
Ciprofloxacin hydrochloride
,
Ciprofloxacin lactate
💬
| - | - | 2件: 96 96, 299 💬
|
| 286 | Clarithromycin | 1件: Clarithromycin Clarithromycin | 1件: Clarithromycin
Clarithromycin
💬
| - | - | 8件: 6 6, 46, 63, 84, 96, 97, 228, 299 💬
|
| 287 | Clinimacs® TCR A/ß reagent KIT and clinimacs® CD19 system | - | - | - | - | 3件: 19 19, 96, 222 💬
|
| 288 | Clofarabine | 1件: Clofarabine Clofarabine | 1件: Clofarabine
Clofarabine
💬
| 3件: POLA1 POLA1, POLA2, RRM1 💬
| 5件: DNA replication DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 5件: 19 19, 20, 60, 96, 234 💬
|
| 289 | Clofazimine | 1件: Clofazimine Clofazimine | 1件: Clofazimine
Clofazimine
💬
| - | - | 1件: 96 96 💬
|
| 290 | Cnto 1275 | - | - | - | - | 2件: 13 13, 96 💬
|
| 291 | CNTO1275 | - | - | - | - | 6件: 46 46, 49, 84, 93, 96, 97 💬
|
| 292 | CNTO148 | - | - | - | - | 5件: 46 46, 84, 96, 97, 107 💬
|
| 293 | CNTO1959 | - | - | - | - | 4件: 37 37, 41, 96, 97 💬
|
| 294 | Coffee | - | - | - | - | 1件: 96 96 💬
|
| 295 | Colecalciferol | 1件: Cholecalciferol Cholecalciferol | 1件: Cholecalciferol
Cholecalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 5件: 13 13, 46, 96, 97, 228 💬
|
| 296 | Colesevelam | 1件: Colesevelam Colesevelam | 2件: Colesevelam hydrochloride
Colesevelam hydrochloride
,
Colesevelam
💬
| - | - | 1件: 96 96 💬
|
| 297 | Colonoscopy | - | - | - | - | 2件: 96 96, 97 💬
|
| 298 | Colovit capsule | - | - | - | - | 1件: 96 96 💬
|
| 299 | Comparator | - | - | - | - | 1件: 96 96 💬
|
| 300 | Computed tomography | - | - | - | - | 12件: 26 26, 28, 40, 46, 49, 60, 62, 65, 96, 284, 285, 286 💬
|
| 301 | Contrast enhanced ultrasound | - | - | - | - | 1件: 96 96 💬
|
| 302 | Contrast media, magnetic resonance | - | - | - | - | 2件: 94 94, 96 💬
|
| 303 | Control diet | - | - | - | - | 2件: 96 96, 97 💬
|
| 304 | Conventional treatment | - | - | - | - | 2件: 96 96, 97 💬
|
| 305 | Coolonic biopsies | - | - | - | - | 2件: 96 96, 97 💬
|
| 306 | COQ10 | 1件: Ubidecarenone Ubidecarenone | 1件: Ubidecarenone
Ubidecarenone
💬
| - | - | 4件: 5 5, 6, 8, 96 💬
|
| 307 | Cortecosteroid | - | - | - | - | 1件: 96 96 💬
|
| 308 | Corticosteroid | - | - | - | - | 7件: 13 13, 66, 84, 96, 97, 113, 222 💬
|
| 309 | Cosmofer | - | - | - | - | 2件: 96 96, 97 💬
|
| 310 | Cosmofer 50MG/ML solution FOR infusion or injection | - | - | - | - | 2件: 96 96, 97 💬
|
| 311 | CP-461 | - | - | - | - | 1件: 96 96 💬
|
| 312 | CP-690,550 | - | - | - | - | 4件: 46 46, 96, 97, 107 💬
|
| 313 | CP-690,550-10 | - | - | - | - | 5件: 46 46, 96, 97, 107, 271 💬
|
| 314 | CPSI-2364 | - | - | - | - | 1件: 96 96 💬
|
| 315 | Crohn'S disease | - | - | - | - | 3件: 56 56, 96, 97 💬
|
| 316 | Crohn'S disease exclusion diet | - | - | - | - | 1件: 96 96 💬
|
| 317 | Crohns disease exclusion diet + PEN | - | - | - | - | 1件: 96 96 💬
|
| 318 | Crown | - | - | - | - | 1件: 96 96 💬
|
| 319 | CT-P13 | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
| 320 | CTLA4IG | - | - | - | - | 4件: 46 46, 49, 96, 271 💬
|
| 321 | Curcuma longa rhizoma | 1件: Turmeric Turmeric | - | - | - | 1件: 96 96 💬
|
| 322 | Curcumin | 1件: Curcumin Curcumin | - | - | - | 10件: 13 13, 34, 46, 67, 74, 94, 96, 97, 139, 299 💬
|
| 323 | CX401 | - | - | - | - | 1件: 96 96 💬
|
| 324 | CX601 | - | - | - | - | 1件: 96 96 💬
|
| 325 | Cyclophosphamide | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 44件: 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
| 326 | Cyclophosphamide monohydrate | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 4件: 13 13, 60, 96, 256 💬
|
| 327 | Cyltezo | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 328 | CYS | - | - | - | - | 1件: 96 96 💬
|
| 329 | Cytochrome P450 (CYP) substrates | - | - | - | - | 2件: 96 96, 97 💬
|
| 330 | Cytoxan | 1件: Cyclophosphamide Cyclophosphamide | 2件: Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | 2件: 60 60, 96 💬
|
| 331 | D-cura | - | - | - | - | 1件: 96 96 💬
|
| 332 | D9421-C | - | - | - | - | 1件: 96 96 💬
|
| 333 | D9421-C capsule 3 MG | - | - | - | - | 1件: 96 96 💬
|
| 334 | D9421-C, 15MG | - | - | - | - | 1件: 96 96 💬
|
| 335 | D9421-C, 9MG | - | - | - | - | 1件: 96 96 💬
|
| 336 | Darvadstrocel | 1件: Darvadstrocel Darvadstrocel | 1件: Darvadstrocel
Darvadstrocel
💬
| - | - | 1件: 96 96 💬
|
| 337 | DB adalimumab 40 MG EOW | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 338 | DB adalimumab 40 MG EW | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 339 | DB-3Q | - | - | - | - | 1件: 96 96 💬
|
| 340 | Decortin 20 MG | - | - | - | - | 1件: 96 96 💬
|
| 341 | Decortin 5 MG | - | - | - | - | 1件: 96 96 💬
|
| 342 | Dehydroepiandrosterone | 1件: Prasterone Prasterone | 1件: Prasterone
Prasterone
💬
| 3件: AR AR, ESR1, ESR2 💬
| 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 4件: 49 49, 53, 83, 96 💬
|
| 343 | Dekristol 20.000 IE | - | - | - | - | 1件: 96 96 💬
|
| 344 | Delayed release 6 mercaptopurine | - | - | - | - | 1件: 96 96 💬
|
| 345 | Delayed release 6MP or calcitriol VS. purinethol | - | - | - | - | 1件: 96 96 💬
|
| 346 | Denosumab | 1件: Denosumab Denosumab | 1件: Denosumab
Denosumab
💬
| 1件: TNFSF11 TNFSF11 💬
| 8件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | 10件: 46 46, 50, 70, 75, 77, 93, 95, 96, 274, 299 💬
|
| 347 | Deucravacitinib | 1件: Deucravacitinib Deucravacitinib | 1件: Deucravacitinib
Deucravacitinib
💬
| 1件: TYK2 TYK2 💬
| 17件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis 💬 | 9件: 36 36, 37, 49, 53, 84, 96, 97, 160, 269 💬
|
| 348 | Dexa scan | - | - | - | - | 4件: 19 19, 46, 96, 299 💬
|
| 349 | Dexametasone sodium phosphate | - | - | - | - | 2件: 96 96, 97 💬
|
| 350 | Dexamethasone | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 22件: 13 13, 14, 16, 19, 28, 35, 63, 64, 70, 74, 75, 81, 84, 90, 96, 97, 222, 235, 257, 296, 299, 331 💬
|
| 351 | Dexamethasone sodium phosphate 250 MG/ 10 ML | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 💬
|
| 352 | Dextromethorphan | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 8件: 6 6, 8, 13, 21, 85, 96, 97, 156 💬
|
| 353 | Dextromethorphan 30 MG | 1件: Dextromethorphan Dextromethorphan | 3件: Dextromethorphan hydrobromide
Dextromethorphan hydrobromide
,
Dextromethorphan
,
Daunorubicin
💬
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 354 | Dhea | 1件: Prasterone Prasterone | 1件: Prasterone
Prasterone
💬
| 3件: AR AR, ESR1, ESR2 💬
| 12件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 2件: 49 49, 96 💬
|
| 355 | Diet 1 | - | - | - | - | 2件: 96 96, 97 💬
|
| 356 | Diet 2 | - | - | - | - | 2件: 96 96, 97 💬
|
| 357 | Dietary therapy | - | - | - | - | 2件: 96 96, 97 💬
|
| 358 | Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphtalen-2-ylmethyl]-ammonium chloride MON | - | - | - | - | 1件: 96 96 💬
|
| 359 | Dietician designed diet | - | - | - | - | 1件: 96 96 💬
|
| 360 | Diflucan | 1件: Fluconazole Fluconazole | 1件: Fluconazole
Fluconazole
💬
| - | - | 1件: 96 96 💬
|
| 361 | Digestible maltodextrin | - | - | - | - | 1件: 96 96 💬
|
| 362 | Diphenhydramine | 1件: Diphenhydramine Diphenhydramine | 4件: Diphenhydramine
Diphenhydramine
,
Diphenhydramine hydrochloride
,
Diphenhydramine salicylate
,
Diphenhydramine citrate
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 10件: 13 13, 19, 49, 51, 70, 86, 96, 222, 256, 300 💬
|
| 363 | Dipyridamole | 1件: Dipyridamole Dipyridamole | 1件: Dipyridamole
Dipyridamole
💬
| 2件: PDE4 PDE4, PDE5 💬
| 5件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 46 46, 51, 66, 96 💬
|
| 364 | DLX105 | - | - | - | - | 1件: 96 96 💬
|
| 365 | Doxycycline | 1件: Doxycycline Doxycycline | 5件: Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | 13件: 23 23, 28, 34, 46, 84, 89, 96, 97, 158, 161, 162, 280, 299 💬
|
| 366 | Doxycycline hyclate | 1件: Doxycycline Doxycycline | 5件: Doxycycline
Doxycycline
,
Doxycycline hyclate
,
Doxycycline calcium
,
Doxycycline
,
Doxycycline hydrochloride
💬
| - | - | 3件: 23 23, 96, 227 💬
|
| 367 | E-device | - | - | - | - | 3件: 46 46, 96, 271 💬
|
| 368 | E6011 | - | - | - | - | 4件: 46 46, 93, 96, 97 💬
|
| 369 | E6011 10 MG/KG | - | - | - | - | 1件: 96 96 💬
|
| 370 | E6011 15 MG/KG | - | - | - | - | 1件: 96 96 💬
|
| 371 | E6011 2 MG/KG | - | - | - | - | 1件: 96 96 💬
|
| 372 | E6011 5 MG/KG | - | - | - | - | 1件: 96 96 💬
|
| 373 | Early biologic therapy | - | - | - | - | 1件: 96 96 💬
|
| 374 | Early faecal calprotectin dosage | - | - | - | - | 1件: 96 96 💬
|
| 375 | EB8018 | - | - | - | - | 1件: 96 96 💬
|
| 376 | Ebetrex 15 MG = 0,75 ML, oplossing voor injectie IN voorgevulde injectiespuit 20 MG/ML | - | - | - | - | 2件: 96 96, 97 💬
|
| 377 | Ebfahf-2 | - | - | - | - | 1件: 96 96 💬
|
| 378 | EEN | - | - | - | - | 1件: 96 96 💬
|
| 379 | EEN intervention group | - | - | - | - | 1件: 96 96 💬
|
| 380 | Efalizumab | 1件: Efalizumab Efalizumab | 1件: Efalizumab
Efalizumab
💬
| 1件: ITGAL ITGAL 💬
| 12件: Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | 9件: 11 11, 13, 37, 46, 53, 61, 95, 96, 221 💬
|
| 381 | Efmarodocokin alfa | 1件: Efmarodocokin alfa Efmarodocokin alfa | 1件: Efmarodocokin alfa
Efmarodocokin alfa
💬
| 1件: IL22 IL22 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Th17 cell differentiation 💬 | 2件: 96 96, 97 💬
|
| 382 | EGG albumen powder | 2件: Egg Egg, Egg white | - | - | - | 1件: 96 96 💬
|
| 383 | EGG white protein | 2件: Egg Egg, Egg white | - | - | - | 1件: 96 96 💬
|
| 384 | Eicosapentaenoic acid | 1件: Icosapent Icosapent | 1件: Icosapent
Icosapent
💬
| - | - | 6件: 49 49, 96, 97, 296, 297, 338 💬
|
| 385 | Emea/H/C/000240 | - | - | - | - | 2件: 96 96, 97 💬
|
| 386 | Emea/H/C/002576 | - | - | - | - | 2件: 96 96, 97 💬
|
| 387 | Emea/H/C/002778 | - | - | - | - | 1件: 96 96 💬
|
| 388 | Empagliflozin | 1件: Empagliflozin Empagliflozin | 1件: Empagliflozin
Empagliflozin
💬
| - | - | 10件: 65 65, 67, 72, 77, 86, 96, 97, 257, 298, 299 💬
|
| 389 | Endoscopic balloon dilatation | - | - | - | - | 1件: 96 96 💬
|
| 390 | Endoxan baxter | - | - | - | - | 3件: 13 13, 43, 96 💬
|
| 391 | Entecavir | 1件: Entecavir Entecavir | 2件: Entecavir
Entecavir
,
Entecavir
💬
| - | - | 6件: 46 46, 56, 96, 97, 107, 271 💬
|
| 392 | Enteral nutrition | - | - | - | - | 2件: 96 96, 97 💬
|
| 393 | Enteral nutrition biscuits | - | - | - | - | 1件: 96 96 💬
|
| 394 | Enteral nutritional suspension | - | - | - | - | 1件: 96 96 💬
|
| 395 | Entocort | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 💬
|
| 396 | Entocort CR | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 2件: 96 96, 97 💬
|
| 397 | Entocort® kapseln | 1件: Budesonide Budesonide | 1件: Budesonide
Budesonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 💬
|
| 398 | Entyvio | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 3件: 94 94, 96, 97 💬
|
| 399 | Epanova | - | - | - | - | 1件: 96 96 💬
|
| 400 | ERB-041 | - | - | - | - | 3件: 46 46, 96, 226 💬
|
| 401 | Ergocalciferol | 1件: Ergocalciferol Ergocalciferol | 1件: Ergocalciferol
Ergocalciferol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 5件: 46 46, 84, 96, 97, 299 💬
|
| 402 | ERY-DEX | - | - | - | - | 1件: 96 96 💬
|
| 403 | Erythropoietin | 1件: Erythropoietin Erythropoietin | 4件: Epoetin alfa
Epoetin alfa
,
Epoetin epsilon
,
Epoetin theta
,
Epoetin zeta
💬
| 1件: EPOR EPOR 💬
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 10件: 2 2, 6, 13, 18, 22, 47, 61, 70, 95, 96 💬
|
| 404 | Eskazole | 1件: Albendazole Albendazole | 1件: Albendazole
Albendazole
💬
| - | - | 1件: 96 96 💬
|
| 405 | Esketamine | 1件: Esketamine Esketamine | 2件: Esketamine
Esketamine
,
Esketamine hydrochloride
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 5件: 2 2, 4, 6, 96, 97 💬
|
| 406 | Etiprednol dicloacetate | 1件: Etiprednol dicloacetate Etiprednol dicloacetate | 1件: Etiprednol dicloacetate
Etiprednol dicloacetate
💬
| - | - | 1件: 96 96 💬
|
| 407 | Etrasimod | 1件: Etrasimod Etrasimod | 2件: Etrasimod
Etrasimod
,
Etrasimod arginine
💬
| 3件: S1PR1 S1PR1, S1PR4, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 96 96, 97, 98 💬
|
| 408 | Etrasimod L-arginine | 1件: Etrasimod Etrasimod | 2件: Etrasimod
Etrasimod
,
Etrasimod arginine
💬
| 3件: S1PR1 S1PR1, S1PR4, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 96 96, 97, 98 💬
|
| 409 | Etrolizumab | 1件: Etrolizumab Etrolizumab | 1件: Etrolizumab
Etrolizumab
💬
| 1件: ITGB7 ITGB7 💬
| 12件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer 💬 | 2件: 96 96, 97 💬
|
| 410 | EU/1/03/268/002 | - | - | - | - | 1件: 96 96 💬
|
| 411 | EU/1/99/116/003 | - | - | - | - | 1件: 96 96 💬
|
| 412 | EUA with seton placement IF necessary | - | - | - | - | 1件: 96 96 💬
|
| 413 | EUS | - | - | - | - | 1件: 96 96 💬
|
| 414 | Everolimus | 1件: Everolimus Everolimus | 1件: Everolimus
Everolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 9件: 34 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
|
| 415 | Exclusion diet | - | - | - | - | 1件: 96 96 💬
|
| 416 | Exclusive enteral nutrition | - | - | - | - | 1件: 96 96 💬
|
| 417 | Exclusive enteral nutrition therapy | - | - | - | - | 1件: 96 96 💬
|
| 418 | Exclusive enteral nutrition treatment group | - | - | - | - | 1件: 96 96 💬
|
| 419 | EXL01 | - | - | - | - | 1件: 96 96 💬
|
| 420 | Exoflo | - | - | - | - | 2件: 96 96, 97 💬
|
| 421 | Expanded allogenic adipose-derived adult stem cells | - | - | - | - | 1件: 96 96 💬
|
| 422 | Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eascs | - | - | - | - | 1件: 96 96 💬
|
| 423 | Expanded human allogenic mesenchymal adult stem cells extracted from adiposetissue (eascs) | - | - | - | - | 1件: 96 96 💬
|
| 424 | Extracorporeal photopheresis | - | - | - | - | 3件: 13 13, 46, 96 💬
|
| 425 | Faecal microbiota transplantation | - | - | - | - | 5件: 46 46, 84, 96, 97, 271 💬
|
| 426 | FAT stem cell | - | - | - | - | 1件: 96 96 💬
|
| 427 | FE 999301 | - | - | - | - | 2件: 96 96, 97 💬
|
| 428 | Feasibility OF BETA-hydroxybutyrate supplementation TO reduce inflammation IN patients with crohn'S | - | - | - | - | 2件: 96 96, 97 💬
|
| 429 | Fecal microbial transplant | - | - | - | - | 3件: 46 46, 96, 97 💬
|
| 430 | Fecal microbial transplantation | - | - | - | - | 2件: 96 96, 97 💬
|
| 431 | Fecal microbiota | 1件: Fecal microbiota Fecal microbiota | - | - | - | 5件: 13 13, 49, 93, 96, 97 💬
|
| 432 | Fecal microbiota transplant | 1件: Fecal microbiota Fecal microbiota | - | - | - | 3件: 6 6, 96, 97 💬
|
| 433 | Fecal microbiota transplantation | 1件: Fecal microbiota Fecal microbiota | - | - | - | 10件: 2 2, 6, 13, 63, 66, 94, 96, 97, 99, 271 💬
|
| 434 | Ferric carboxy maltose | - | - | - | - | 2件: 96 96, 97 💬
|
| 435 | Ferric carboxymaltose | 1件: Ferric carboxymaltose Ferric carboxymaltose | 1件: Ferric carboxymaltose
Ferric carboxymaltose
💬
| - | - | 4件: 86 86, 96, 97, 299 💬
|
| 436 | Ferric maltol | 1件: Ferric maltol Ferric maltol | 1件: Ferric maltol
Ferric maltol
💬
| - | - | 2件: 96 96, 97 💬
|
| 437 | Ferrous sulphate | - | - | - | - | 2件: 96 96, 97 💬
|
| 438 | FFP104 | - | - | - | - | 2件: 93 93, 96 💬
|
| 439 | Fibrin glue injection IN fistula | 1件: Fibrin Fibrin | - | - | - | 1件: 96 96 💬
|
| 440 | Filgotinib | 1件: Filgotinib Filgotinib | 2件: Filgotinib
Filgotinib
,
Filgotinib maleate
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 10件: 46 46, 53, 56, 96, 97, 107, 222, 271, 300, 331 💬
|
| 441 | Filgrastim | 1件: Filgrastim Filgrastim | 1件: Filgrastim
Filgrastim
💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 29件: 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
|
| 442 | FILM-coated tablet | - | - | - | - | 2件: 96 96, 97 💬
|
| 443 | Fish OIL | 1件: Fish oil Fish oil | - | - | - | 5件: 13 13, 46, 49, 96, 299 💬
|
| 444 | FITC-adalimumab | - | - | - | - | 2件: 96 96, 97 💬
|
| 445 | Flagyl | 1件: Metronidazole Metronidazole | 2件: Metronidazole
Metronidazole
,
Metronidazole hydrochloride
💬
| - | - | 2件: 96 96, 97 💬
|
| 446 | Flixabi | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 447 | Fluconazole | 1件: Fluconazole Fluconazole | 1件: Fluconazole
Fluconazole
💬
| - | - | 2件: 96 96, 225 💬
|
| 448 | Fludarabine | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 23件: 11 11, 13, 19, 34, 35, 36, 44, 46, 49, 51, 60, 61, 62, 65, 85, 96, 107, 164, 222, 283, 284, 285, 326 💬
|
| 449 | Fludarabine phosphate | 1件: Fludarabine Fludarabine | 2件: Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| 1件: RRM1 RRM1 💬
| 4件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | 12件: 28 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285, 286 💬
|
| 450 | Fluorescence molecular imaging procedure using vedolizumab-800CW with prior administration OF unlabeled vedolizumab | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 💬
|
| 451 | Fluorescence molecular imaging procedure without prior administration OF vedolizumab-800CW | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 💬
|
| 452 | Fluorine F 18 clofarabine | - | - | - | - | 4件: 40 40, 46, 49, 96 💬
|
| 453 | FMT | - | - | - | - | 3件: 96 96, 97, 271 💬
|
| 454 | Folacin | 1件: Folic acid Folic acid | 2件: Folic acid
Folic acid
,
Folate sodium
💬
| - | - | 2件: 96 96, 97 💬
|
| 455 | Folic acid | 1件: Folic acid Folic acid | 2件: Folic acid
Folic acid
,
Folate sodium
💬
| - | - | 6件: 46 46, 84, 96, 97, 172, 296 💬
|
| 456 | Foralumab | 1件: Foralumab Foralumab | - | - | - | 2件: 13 13, 96 💬
|
| 457 | Formula | - | - | - | - | 1件: 96 96 💬
|
| 458 | FOS | - | - | - | - | 2件: 66 66, 96 💬
|
| 459 | Fosfato sodico DE dexametasona | 1件: Dexamethasone Dexamethasone | 3件: Dexamethasone
Dexamethasone
,
Dexamethasone sodium phosphate
,
Dexamethasone phosphate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 💬
|
| 460 | Fosfomycin | 1件: Fosfomycin Fosfomycin | 3件: Fosfomycin tromethamine
Fosfomycin tromethamine
,
Fosfomycin sodium
,
Fosfomycin
💬
| - | - | 2件: 96 96, 97 💬
|
| 461 | Freeze dried grape powder | - | - | - | - | 2件: 96 96, 97 💬
|
| 462 | Fully human IGG1 monoclonal antibody specific FOR TL1A | - | - | - | - | 2件: 96 96, 97 💬
|
| 463 | G-CSF | 1件: Filgrastim Filgrastim | 1件: Filgrastim
Filgrastim
💬
| 1件: CSF3R CSF3R 💬
| 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 18件: 2 2, 6, 11, 13, 16, 22, 47, 49, 51, 60, 61, 62, 65, 85, 96, 284, 285, 331 💬
|
| 464 | G321605 | - | - | - | - | 3件: 85 85, 96, 97 💬
|
| 465 | GED-0301 | - | - | - | - | 2件: 96 96, 97 💬
|
| 466 | Genetic analysis | - | - | - | - | 7件: 34 34, 85, 90, 93, 94, 96, 234 💬
|
| 467 | Genome-wide DNA methylation | - | - | - | - | 1件: 96 96 💬
|
| 468 | Glatiramer acetate | 1件: Glatiramer Glatiramer | 1件: Glatiramer acetate
Glatiramer acetate
💬
| 20件: MHC1 MHC1, MHC1, MHC1, MHC1, MHC1, MHC1, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2, MHC2 💬
| 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 3件: 13 13, 96, 156 💬
|
| 469 | Gliolan | - | - | - | - | 1件: 96 96 💬
|
| 470 | GLPG0634 | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
| 471 | GLPG1205 | - | - | - | - | 3件: 85 85, 96, 97 💬
|
| 472 | Glucagon | 1件: Glucagon Glucagon | 2件: Glucagon
Glucagon
,
Glucagon hydrochloride
💬
| 1件: GCGR GCGR 💬
| 3件: Glucagon signaling pathway Glucagon signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 💬
|
| 473 | Glucocorticoids | - | - | - | - | 10件: 35 35, 40, 41, 43, 44, 75, 96, 221, 222, 300 💬
|
| 474 | Glucose | 1件: Dextrose, unspecified form Dextrose, unspecified form | 2件: Dextrose
Dextrose
,
Glucose, liquid
💬
| - | - | 9件: 6 6, 13, 66, 77, 96, 97, 226, 254, 299 💬
|
| 475 | Glutamine | 1件: L-Glutamine L-Glutamine | 1件: Glutamine
Glutamine
💬
| - | - | 10件: 87 87, 89, 96, 97, 113, 214, 215, 222, 245, 299 💬
|
| 476 | Glycan | - | - | - | - | 1件: 96 96 💬
|
| 477 | Golimumab | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 8件: 46 46, 56, 84, 96, 97, 107, 270, 271 💬
|
| 478 | Green TEA | 1件: Green tea leaf Green tea leaf | 1件: Green tea leaf
Green tea leaf
💬
| - | - | 3件: 6 6, 28, 96 💬
|
| 479 | Group 2 ustekinumab 130 MG | - | - | - | - | 2件: 96 96, 97 💬
|
| 480 | Group 3: ustekinumab approximately 6 MG/KG | - | - | - | - | 2件: 96 96, 97 💬
|
| 481 | Growth hormone | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 16件: 2 2, 19, 46, 77, 78, 96, 97, 107, 113, 156, 191, 193, 195, 238, 265, 299 💬
|
| 482 | GS-5745 | 1件: GS-5745 GS-5745 | - | - | - | 4件: 46 46, 96, 97, 299 💬
|
| 483 | GS-6034 | - | - | - | - | 4件: 46 46, 53, 96, 97 💬
|
| 484 | GSK1070806 | - | - | - | - | 2件: 56 56, 96 💬
|
| 485 | GSK1605786 | - | - | - | - | 2件: 96 96, 97 💬
|
| 486 | GSK1605786 500 MG | - | - | - | - | 1件: 96 96 💬
|
| 487 | GSK1605786 capsule | - | - | - | - | 1件: 96 96 💬
|
| 488 | GSK1605786 chemocentryx: formulation A | - | - | - | - | 1件: 96 96 💬
|
| 489 | GSK1605786 GSK direct-fill: formulation C | - | - | - | - | 1件: 96 96 💬
|
| 490 | GSK1605786 GSK modified-process: formulation D | - | - | - | - | 1件: 96 96 💬
|
| 491 | GSK1605786 GSK tablet: formulation E | - | - | - | - | 1件: 96 96 💬
|
| 492 | GSK1605786 GSK: formulation B | - | - | - | - | 1件: 96 96 💬
|
| 493 | GSK1605786A | - | - | - | - | 2件: 96 96, 97 💬
|
| 494 | GSK2330811 | - | - | - | - | 2件: 51 51, 96 💬
|
| 495 | Guselkumab | 1件: Guselkumab Guselkumab | 1件: Guselkumab
Guselkumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 6件: 37 37, 41, 96, 97, 161, 269 💬
|
| 496 | Guselkumab dose 1 | 1件: Guselkumab Guselkumab | 1件: Guselkumab
Guselkumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 3件: 51 51, 96, 97 💬
|
| 497 | Guselkumab dose 2 | 1件: Guselkumab Guselkumab | 1件: Guselkumab
Guselkumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 3件: 51 51, 96, 97 💬
|
| 498 | Guselkumab dose 3 | 1件: Guselkumab Guselkumab | 1件: Guselkumab
Guselkumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
| 499 | Guselkumab dose 4 | 1件: Guselkumab Guselkumab | 1件: Guselkumab
Guselkumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 96 96 💬
|
| 500 | Guselkumab dose 5 | 1件: Guselkumab Guselkumab | 1件: Guselkumab
Guselkumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 96 96 💬
|
| 501 | Hematopoietic stem cell transplantation | - | - | - | - | 13件: 11 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 💬
|
| 502 | Hepatitis A vaccine | 1件: Hepatitis A Vaccine Hepatitis A Vaccine | - | - | - | 3件: 46 46, 96, 97 💬
|
| 503 | Herpes zoster vaccine | - | - | - | - | 9件: 46 46, 49, 50, 51, 53, 56, 96, 107, 271 💬
|
| 504 | Hextend | - | - | - | - | 2件: 96 96, 97 💬
|
| 505 | High dose TSO | - | - | - | - | 1件: 96 96 💬
|
| 506 | High oligosaccharide group | - | - | - | - | 1件: 96 96 💬
|
| 507 | High performance liquid chromatography | - | - | - | - | 1件: 96 96 💬
|
| 508 | High serine diet | - | - | - | - | 1件: 96 96 💬
|
| 509 | HIGH-dose cyclophosphamide | - | - | - | - | 1件: 96 96 💬
|
| 510 | Hladqa1*05A>G screening | - | - | - | - | 2件: 96 96, 97 💬
|
| 511 | HM201 | - | - | - | - | 2件: 96 96, 97 💬
|
| 512 | HMPL-004 | - | - | - | - | 2件: 96 96, 97 💬
|
| 513 | HMPL004-6599 | - | - | - | - | 2件: 96 96, 97 💬
|
| 514 | Hulio | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 515 | HUM291 | - | - | - | - | 2件: 96 96, 97 💬
|
| 516 | Human albumin AS macroaggregates | 1件: Albumin human Albumin human | 2件: Albumin human
Albumin human
,
Human serum albumin
💬
| - | - | 1件: 96 96 💬
|
| 517 | Human ANTI-IL-12 antibody | - | - | - | - | 1件: 96 96 💬
|
| 518 | Human ANTI-IP10 monoclonal antibody | - | - | - | - | 2件: 96 96, 97 💬
|
| 519 | Human placenta-derived cells PDA001 intravenous infusion | - | - | - | - | 1件: 96 96 💬
|
| 520 | Human plasma FOR fractionation | - | - | - | - | 1件: 96 96 💬
|
| 521 | Human TH-SC01 cell injection | - | - | - | - | 1件: 96 96 💬
|
| 522 | Human umbilical cord mesenchymal stem cells | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 4件: 13 13, 96, 113, 271 💬
|
| 523 | Humira | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 9件: 46 46, 56, 84, 96, 97, 107, 160, 269, 271 💬
|
| 524 | Humira - 40MG/0.8ML soluz. iniettabile- USO sottocutaneo-flaconcino(vetro) 0.8ML 2 astucci:1 flaconcino+1siringa+1AGO+1adatt.sterile-2tamponi imbevuti alcool | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 96 💬
|
| 525 | Humira 20 MG solution FOR injection IN PRE-filled syringe | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 526 | Humira 40 MG injekcní roztok V predplnené injekcní STRíkacce | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 527 | Humira 40 MG solucióN inyectable EN jeringa precargada | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 96 💬
|
| 528 | Humira 40 MG solution FOR injection IN PRE-filled PEN | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 529 | Humira 40 MG solution FOR injection IN PRE-filled syringe | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 46 46, 96, 97 💬
|
| 530 | Humira 40 MG/0.8 ML solution FOR injection | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 4件: 46 46, 96, 97, 271 💬
|
| 531 | Humira 40MG solution FOR injection | - | - | - | - | 2件: 96 96, 97 💬
|
| 532 | Humira 40MG/0.4ML PRE-filled syringe | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 533 | Humira 40MG/0.8ML solution FOR injection FOR paediatric USE | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 534 | Humira PRE-filled PEN | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 535 | Humira*SC 2SIR+F 40MG 0,8ML+2T | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 96 💬
|
| 536 | Hydroxychloroquine | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 26件: 6 6, 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 63, 66, 84, 96, 97, 107, 218, 222, 224, 234, 254, 271, 298, 299 💬
|
| 537 | Hydroxychloroquine sulphate | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 1件: 96 96 💬
|
| 538 | Hyperbaric oxygen | - | - | - | - | 4件: 46 46, 96, 97, 269 💬
|
| 539 | Hypnosis | - | - | - | - | 1件: 96 96 💬
|
| 540 | ICG-guided bowel perfusion assessment | - | - | - | - | 1件: 96 96 💬
|
| 541 | IGG2 antibodies | - | - | - | - | 2件: 96 96, 97 💬
|
| 542 | IL-23 therapy | - | - | - | - | 1件: 96 96 💬
|
| 543 | Ileocecal resection | - | - | - | - | 1件: 96 96 💬
|
| 544 | Ileocolonic biopsies | - | - | - | - | 1件: 96 96 💬
|
| 545 | Ileocolonoscopy | - | - | - | - | 1件: 96 96 💬
|
| 546 | IM90838 | - | - | - | - | 3件: 13 13, 96, 97 💬
|
| 547 | Immune ablation and hematopoietic stem cell support | - | - | - | - | 1件: 96 96 💬
|
| 548 | Immunonutrition | - | - | - | - | 2件: 96 96, 226 💬
|
| 549 | Immunosuppressant | - | - | - | - | 2件: 96 96, 224 💬
|
| 550 | Immunosuppressive agents | - | - | - | - | 4件: 13 13, 50, 96, 220 💬
|
| 551 | Immunosuppressor/tnfalpha | - | - | - | - | 1件: 96 96 💬
|
| 552 | Immunotherapy | - | - | - | - | 2件: 96 96, 97 💬
|
| 553 | IMP will BE labeled AS PF-04236921 106MG/vial, clonal SC lyophilized form | - | - | - | - | 1件: 96 96 💬
|
| 554 | Imraldi | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 555 | IMU-838 | - | - | - | - | 3件: 13 13, 96, 97 💬
|
| 556 | Imuran | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 2件: 96 96, 97 💬
|
| 557 | Imurel | - | - | - | - | 7件: 13 13, 44, 45, 46, 54, 96, 97 💬
|
| 558 | Imurel 25 MG | - | - | - | - | 3件: 44 44, 45, 96 💬
|
| 559 | Increlex | 1件: Mecasermin Mecasermin | 2件: Mecasermin
Mecasermin
,
Mecasermin rinfabate
💬
| 2件: GHR GHR, IGF1R 💬
| 32件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Hormone signaling, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | 2件: 65 65, 96 💬
|
| 560 | Increlex 10MG/ML solution FOR injection | 1件: Mecasermin Mecasermin | 2件: Mecasermin
Mecasermin
,
Mecasermin rinfabate
💬
| 2件: GHR GHR, IGF1R 💬
| 32件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Hormone signaling, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 561 | Indocyanine green | 2件: Indocyanine green Indocyanine green, Water | 2件: Water
Water
,
Indocyanine green
💬
| - | - | 8件: 22 22, 46, 51, 96, 235, 278, 291, 296 💬
|
| 562 | Inflectra | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 46 46, 96, 97 💬
|
| 563 | Inflectra 100 MG powder FOR concentrate FOR solution FOR infusion | - | - | - | - | 2件: 96 96, 97 💬
|
| 564 | Infliximab | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 24件: 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 164, 269, 270, 271 💬
|
| 565 | Infliximab (IFX) infusion | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 566 | Infliximab (remicade): 100 MG OF lyophilized infliximab | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 567 | Infliximab 10 MG/KG | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 46 46, 96, 97 💬
|
| 568 | Infliximab 20 MG/KG | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 569 | Infliximab 5 MG/KG | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 570 | Infliximab 5 MG/KG body weight infused over 2 hours | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 571 | Infliximab 5 MG/KG every 6 weeks | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 572 | Infliximab 7 MG/KG every 8 weeks | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 573 | Infliximab and adalimumab | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 574 | Infliximab and azathioprine combination AT week 0 | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 575 | Infliximab and azathioprine combination AT week 14 | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 576 | Infliximab and immunosuppressives | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 577 | Infliximab infusion | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 4件: 46 46, 96, 97, 271 💬
|
| 578 | Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab or tofacitinib | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 579 | Infliximab subcutaneous | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 580 | Infliximab therapeutic drug monitoring | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 581 | Infliximab+azathioprine | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 582 | Infliximab, adalimumab, certolizumab pegol | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 583 | Infliximab, azathioprine | 2件: Azathioprine Azathioprine, Infliximab | 3件: Azathioprine
Azathioprine
,
Infliximab
,
Azathioprine sodium
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 584 | Infliximab-biosimilar | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 585 | Infliximab-dyyb | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 586 | Infliximab-innovator | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 587 | Injection OF iron | - | - | - | - | 1件: 96 96 💬
|
| 588 | Innovator infliximab | - | - | - | - | 3件: 46 46, 96, 97 💬
|
| 589 | Inositol | 1件: Inositol Inositol | 1件: Inositol
Inositol
💬
| - | - | 2件: 96 96, 97 💬
|
| 590 | Instillation OF fibrin glue | - | - | - | - | 1件: 96 96 💬
|
| 591 | Intensify treatment with THE existing drug | - | - | - | - | 2件: 96 96, 97 💬
|
| 592 | Interferon BETA-1A | 2件: Human interferon beta Human interferon beta, Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 3件: 13 13, 96, 97 💬
|
| 593 | Interferon gamma | 1件: Interferon Gamma Interferon Gamma | - | - | - | 3件: 65 65, 96, 326 💬
|
| 594 | Interleukin 2 | - | - | - | - | 11件: 35 35, 46, 49, 51, 56, 63, 95, 96, 97, 162, 271 💬
|
| 595 | Interleukin-11 | 1件: Oprelvekin Oprelvekin | 1件: Oprelvekin
Oprelvekin
💬
| 1件: IL11RA IL11RA 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 596 | Interleukin-2 | 1件: Human interleukin-2 Human interleukin-2 | - | - | - | 9件: 2 2, 13, 49, 50, 55, 65, 96, 97, 162 💬
|
| 597 | Intestinal resection | - | - | - | - | 1件: 96 96 💬
|
| 598 | Intestinal surgery FOR crohn'S disease | - | - | - | - | 1件: 96 96 💬
|
| 599 | Intralipid | - | - | - | - | 1件: 96 96 💬
|
| 600 | Intrinsically labelled protein | - | - | - | - | 1件: 96 96 💬
|
| 601 | Investigational product | - | - | - | - | 1件: 96 96 💬
|
| 602 | Invita D3 | - | - | - | - | 1件: 96 96 💬
|
| 603 | Iodine | 1件: Iodine Iodine | 1件: Iodine
Iodine
💬
| - | - | 3件: 28 28, 46, 96 💬
|
| 604 | Iron | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 4件: 60 60, 96, 97, 238 💬
|
| 605 | Iron sucrose | 2件: Iron Iron, Iron sucrose | 2件: Ferrous fumarate
Ferrous fumarate
,
Iron sucrose
💬
| - | - | 3件: 62 62, 96, 97 💬
|
| 606 | Iron sulphate 200MG coated tablets | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 2件: 96 96, 97 💬
|
| 607 | Iron supplement 300-600 MG/DAY | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 2件: 96 96, 97 💬
|
| 608 | Iron(III)- hydroxide dextran complex | 1件: Iron Iron | 1件: Ferrous fumarate
Ferrous fumarate
💬
| - | - | 2件: 96 96, 97 💬
|
| 609 | ITF 2357 | - | - | - | - | 1件: 96 96 💬
|
| 610 | ITF2357 | - | - | - | - | 4件: 96 96, 107, 113, 267 💬
|
| 611 | Itraconazole | 1件: Itraconazole Itraconazole | 1件: Itraconazole
Itraconazole
💬
| - | - | 7件: 2 2, 3, 65, 96, 97, 227, 299 💬
|
| 612 | IV saline infusion | - | - | - | - | 1件: 96 96 💬
|
| 613 | IV tulisokibart | - | - | - | - | 2件: 96 96, 97 💬
|
| 614 | J695 | - | - | - | - | 1件: 96 96 💬
|
| 615 | J695, BSF 415977 (formerly LU415977), WAY-165772, A-796874.0 | - | - | - | - | 1件: 96 96 💬
|
| 616 | JNJ-40346527-AAC | 1件: JNJ-40346527 JNJ-40346527 | - | - | - | 1件: 96 96 💬
|
| 617 | JNJ-64304500 | - | - | - | - | 1件: 96 96 💬
|
| 618 | JNJ-64304500-AAA | - | - | - | - | 1件: 96 96 💬
|
| 619 | JNJ-67864238 | - | - | - | - | 1件: 96 96 💬
|
| 620 | JNJ-78934804 | - | - | - | - | 2件: 96 96, 97 💬
|
| 621 | Kanamycin | 1件: Kanamycin Kanamycin | 2件: Kanamycin sulfate
Kanamycin sulfate
,
Kanamycin sulfate
💬
| - | - | 2件: 96 96, 291 💬
|
| 622 | Kenacort | - | - | - | - | 1件: 96 96 💬
|
| 623 | Kleanlyte | - | - | - | - | 2件: 96 96, 97 💬
|
| 624 | Kremezin®, spherical adsorptive carbon | - | - | - | - | 2件: 96 96, 97 💬
|
| 625 | L 44 | - | - | - | - | 1件: 96 96 💬
|
| 626 | L-carnitine | 1件: Levocarnitine Levocarnitine | 2件: Levocarnitine chloride
Levocarnitine chloride
,
Levocarnitine
💬
| - | - | 5件: 13 13, 46, 86, 96, 240 💬
|
| 627 | L01BA | - | - | - | - | 1件: 96 96 💬
|
| 628 | L04ab04 | - | - | - | - | 5件: 46 46, 96, 107, 160, 271 💬
|
| 629 | L04ax01 | - | - | - | - | 1件: 96 96 💬
|
| 630 | Laboratory biomarker analysis | - | - | - | - | 22件: 11 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
|
| 631 | Lactated ringers | - | - | - | - | 2件: 96 96, 97 💬
|
| 632 | Lactobacillus salivarius UCC118 | 1件: Lactobacillus salivarius Lactobacillus salivarius | - | - | - | 2件: 96 96, 97 💬
|
| 633 | Lactulose/rhamnose solution | 1件: Lactulose Lactulose | 1件: Lactulose
Lactulose
💬
| - | - | 1件: 96 96 💬
|
| 634 | LAP TAP bupivacaine/epinephrine | - | - | - | - | 2件: 96 96, 97 💬
|
| 635 | Laquinimod | 1件: Laquinimod Laquinimod | 1件: Laquinimod sodium
Laquinimod sodium
💬
| - | - | 4件: 8 8, 13, 49, 96 💬
|
| 636 | Laquinimod capsules 0.5 MG | 1件: Laquinimod Laquinimod | 1件: Laquinimod sodium
Laquinimod sodium
💬
| - | - | 2件: 8 8, 96 💬
|
| 637 | Laquinimod Cápsulas 0.5 MG | 1件: Laquinimod Laquinimod | 1件: Laquinimod sodium
Laquinimod sodium
💬
| - | - | 1件: 96 96 💬
|
| 638 | Late biologic therapy | - | - | - | - | 1件: 96 96 💬
|
| 639 | LDP-02 | - | - | - | - | 2件: 96 96, 97 💬
|
| 640 | Lengthening adalimumab dosing interval | - | - | - | - | 1件: 96 96 💬
|
| 641 | Leukapheresis | - | - | - | - | 5件: 49 49, 51, 96, 284, 285 💬
|
| 642 | Leukapheresis- collection OF stem cells | - | - | - | - | 1件: 96 96 💬
|
| 643 | Lipitor | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 3件: 51 51, 96, 299 💬
|
| 644 | Liposomal bupivacaine | 1件: Bupivacaine Bupivacaine | 2件: Bupivacaine hydrochloride
Bupivacaine hydrochloride
,
Bupivacaine
💬
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 3件: 51 51, 70, 96 💬
|
| 645 | LMT503 | - | - | - | - | 2件: 96 96, 97 💬
|
| 646 | LO4ab02 | - | - | - | - | 1件: 96 96 💬
|
| 647 | Local injection OF normal saline | - | - | - | - | 1件: 96 96 💬
|
| 648 | Losartan | 1件: Losartan Losartan | 2件: Losartan potassium
Losartan potassium
,
Losartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 15件: 17 17, 19, 46, 58, 66, 67, 85, 96, 97, 113, 164, 167, 215, 222, 299 💬
|
| 649 | LOW dose naltrexone | - | - | - | - | 2件: 96 96, 97 💬
|
| 650 | LOW dose TSO | - | - | - | - | 1件: 96 96 💬
|
| 651 | LOW fiber diet | - | - | - | - | 1件: 96 96 💬
|
| 652 | LOW N-6 pufa diet | - | - | - | - | 1件: 96 96 💬
|
| 653 | LOW serine diet | - | - | - | - | 1件: 96 96 💬
|
| 654 | LOW-dose IL-2 administration | - | - | - | - | 1件: 96 96 💬
|
| 655 | Lumbar puncture | - | - | - | - | 6件: 6 6, 13, 19, 96, 97, 127 💬
|
| 656 | Lumentin 44 | - | - | - | - | 1件: 96 96 💬
|
| 657 | Lutikizumab | 1件: Lutikizumab Lutikizumab | 1件: Lutikizumab
Lutikizumab
💬
| 2件: IL1A IL1A, IL1B 💬
| 44件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | 3件: 46 46, 96, 97 💬
|
| 658 | LY3074828 | - | - | - | - | 2件: 96 96, 97 💬
|
| 659 | Lymphocyte immune globulin | - | - | - | - | 1件: 96 96 💬
|
| 660 | Maltodextrin | 1件: Maltodextrin Maltodextrin | 1件: Maltodextrin
Maltodextrin
💬
| - | - | 4件: 6 6, 13, 96, 97 💬
|
| 661 | Mango polyphenolics | 1件: Mango Mango | - | - | - | 2件: 96 96, 97 💬
|
| 662 | Mannitol | 1件: Mannitol Mannitol | 1件: Mannitol
Mannitol
💬
| - | - | 6件: 6 6, 13, 60, 96, 113, 299 💬
|
| 663 | Mare´S milk | - | - | - | - | 2件: 96 96, 97 💬
|
| 664 | Masitinib mesylate | 1件: Masitinib Masitinib | 1件: Masitinib
Masitinib
💬
| 1件: KIT KIT 💬
| 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 6件: 2 2, 5, 6, 13, 46, 96 💬
|
| 665 | MB-102 | - | - | - | - | 1件: 96 96 💬
|
| 666 | MBF-118 oral capsules | - | - | - | - | 1件: 96 96 💬
|
| 667 | MDGN-002 | - | - | - | - | 1件: 96 96 💬
|
| 668 | MDX-1100 | - | - | - | - | 3件: 46 46, 96, 97 💬
|
| 669 | Measurement OF serum infliximab and ANTI-infliximab antibodies | - | - | - | - | 1件: 96 96 💬
|
| 670 | Mecasermin [rdna origin] 10MG/ML solution | 1件: Mecasermin Mecasermin | 2件: Mecasermin
Mecasermin
,
Mecasermin rinfabate
💬
| 2件: GHR GHR, IGF1R 💬
| 32件: AMPK signaling pathway AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Hormone signaling, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 671 | MEDI2070 | - | - | - | - | 2件: 96 96, 97 💬
|
| 672 | Medical cannabis | 1件: Medical Cannabis Medical Cannabis | 1件: Cannabis
Cannabis
💬
| - | - | 3件: 6 6, 96, 97 💬
|
| 673 | Mediterranean diet | - | - | - | - | 6件: 13 13, 77, 96, 97, 265, 299 💬
|
| 674 | Medium chain triglycerides | - | - | - | - | 2件: 96 96, 97 💬
|
| 675 | Medium dose TSO | - | - | - | - | 1件: 96 96 💬
|
| 676 | Melatonin | 1件: Melatonin Melatonin | 1件: Melatonin
Melatonin
💬
| 2件: MTNR1A MTNR1A, MTNR1B 💬
| 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 16件: 2 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 202 💬
|
| 677 | Melphalan | 1件: Melphalan Melphalan | 2件: Melphalan
Melphalan
,
Melphalan hydrochloride
💬
| - | - | 19件: 11 11, 13, 14, 19, 20, 28, 34, 46, 60, 62, 65, 96, 107, 164, 222, 234, 284, 285, 299 💬
|
| 678 | Mensa | - | - | - | - | 1件: 96 96 💬
|
| 679 | Mercaptopurine | 1件: Mercaptopurine Mercaptopurine | 2件: Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| 1件: hprT hprT 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 2件: 96 96, 97 💬
|
| 680 | Mesalamine | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 3件: 96 96, 97, 164 💬
|
| 681 | Mesalamine, 5-aminosalicylic acid | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 96 96 💬
|
| 682 | Mesalazine | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 3件: 46 46, 96, 97 💬
|
| 683 | Mesalazine EC 500 MG | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 96 96 💬
|
| 684 | Mesalazine sustained-release tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 96 96 💬
|
| 685 | Mesalazine tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 96 96 💬
|
| 686 | Mesalazine, tripterygium glycosides | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 96 96 💬
|
| 687 | Mesenchymal cell and fibroblast injection | - | - | - | - | 1件: 96 96 💬
|
| 688 | Mesenchymal cell transplantation | - | - | - | - | 2件: 46 46, 96 💬
|
| 689 | Mesenchymal stem cells | - | - | - | - | 17件: 2 2, 6, 13, 20, 46, 49, 50, 51, 60, 96, 97, 107, 222, 271, 274, 298, 299 💬
|
| 690 | Mesenchymal stromal cells | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 8件: 36 36, 51, 60, 96, 97, 107, 274, 284 💬
|
| 691 | Mesenchymal stromal cells (MSC) FOR infusion | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 96 96 💬
|
| 692 | Mesna | - | - | - | - | 11件: 11 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬
|
| 693 | Methacholine challenge test | 1件: Methacholine Methacholine | 1件: Methacholine chloride
Methacholine chloride
💬
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| 14件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 96 96 💬
|
| 694 | Methotrexat | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 3件: 13 13, 46, 96 💬
|
| 695 | Methotrexate | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 37件: 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
| 696 | Methotrexate - 20 MG/0.8 ML soluzione iniettabile 4 siringhe preriempite monouso DA 1.25 ML | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 1件: 96 96 💬
|
| 697 | Methotrexate disodium | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 5件: 46 46, 96, 97, 107, 271 💬
|
| 698 | Methotrexate injection | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 2件: 96 96, 97 💬
|
| 699 | Methoxsalen | 1件: Methoxsalen Methoxsalen | 1件: Methoxsalen
Methoxsalen
💬
| - | - | 3件: 36 36, 46, 96 💬
|
| 700 | Methoxsalen +ECP | 1件: Methoxsalen Methoxsalen | 1件: Methoxsalen
Methoxsalen
💬
| - | - | 1件: 96 96 💬
|
| 701 | Methyl prednisolone | - | - | - | - | 2件: 49 49, 96 💬
|
| 702 | Methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 45件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
| 703 | Methylprednisolone or budesonide | 1件: Methylprednisolone Methylprednisolone | 2件: Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 💬
|
| 704 | Metoject | 1件: Methotrexate Methotrexate | 2件: Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| 2件: DHFR DHFR, DHFR 💬
| 3件: Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | 6件: 41 41, 46, 96, 97, 107, 271 💬
|
| 705 | Metotrexat | - | - | - | - | 3件: 50 50, 96, 97 💬
|
| 706 | Metronidazol | 1件: Metronidazole Metronidazole | 2件: Metronidazole
Metronidazole
,
Metronidazole hydrochloride
💬
| - | - | 2件: 46 46, 96 💬
|
| 707 | Metronidazole | 1件: Metronidazole Metronidazole | 2件: Metronidazole
Metronidazole
,
Metronidazole hydrochloride
💬
| - | - | 7件: 46 46, 51, 63, 94, 96, 97, 291 💬
|
| 708 | Metronidazole oral | 1件: Metronidazole Metronidazole | 2件: Metronidazole
Metronidazole
,
Metronidazole hydrochloride
💬
| - | - | 1件: 96 96 💬
|
| 709 | Microbiota | - | - | - | - | 1件: 96 96 💬
|
| 710 | Midazolam | 1件: Midazolam Midazolam | 3件: Midazolam
Midazolam
,
Midazolam hydrochloride
,
Midazolam maleate
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 12件: 2 2, 3, 6, 13, 46, 67, 96, 97, 231, 272, 298, 299 💬
|
| 711 | Midazolam 2 MG | 1件: Midazolam Midazolam | 3件: Midazolam
Midazolam
,
Midazolam hydrochloride
,
Midazolam maleate
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 2件: 96 96, 97 💬
|
| 712 | Midazolam 3 MG | 1件: Midazolam Midazolam | 3件: Midazolam
Midazolam
,
Midazolam hydrochloride
,
Midazolam maleate
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 96 96 💬
|
| 713 | Milk | - | - | - | - | 2件: 96 96, 97 💬
|
| 714 | Mirikizumab | 1件: Mirikizumab Mirikizumab | 1件: Mirikizumab
Mirikizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 3件: 37 37, 96, 97 💬
|
| 715 | MLN0002 | - | - | - | - | 3件: 94 94, 96, 97 💬
|
| 716 | MLN0002 SC | - | - | - | - | 2件: 96 96, 97 💬
|
| 717 | MLN002 | - | - | - | - | 2件: 96 96, 97 💬
|
| 718 | Mobilization OF stem cells TO prepare FOR leukapheresis | - | - | - | - | 1件: 96 96 💬
|
| 719 | Moderate oligosaccharide group | - | - | - | - | 1件: 96 96 💬
|
| 720 | Modulen | - | - | - | - | 1件: 96 96 💬
|
| 721 | Modulen IBD | - | - | - | - | 1件: 96 96 💬
|
| 722 | Mongersen | 1件: Mongersen Mongersen | 1件: Mongersen
Mongersen
💬
| 1件: SMAD7 SMAD7 💬
| 2件: Hippo signaling pathway Hippo signaling pathway, TGF-beta signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 723 | Monoclonal antibodies | - | - | - | - | 1件: 96 96 💬
|
| 724 | Monoclonal antibody ANTI-IGG1 | - | - | - | - | 3件: 37 37, 96, 97 💬
|
| 725 | Monoclonal antibody CA2 | - | - | - | - | 1件: 96 96 💬
|
| 726 | MORF-057 | - | - | - | - | 2件: 96 96, 97 💬
|
| 727 | Mosapride | 1件: Mosapride Mosapride | 1件: Mosapride
Mosapride
💬
| 1件: HTR4 HTR4 💬
| 5件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬 | 1件: 96 96 💬
|
| 728 | Moviprep polvo para solucióN oral | - | - | - | - | 2件: 96 96, 97 💬
|
| 729 | Movprep | - | - | - | - | 1件: 96 96 💬
|
| 730 | MSC | - | - | - | - | 5件: 51 51, 60, 96, 97, 271 💬
|
| 731 | MSC injection 01 | - | - | - | - | 1件: 96 96 💬
|
| 732 | MSC injection 02 | - | - | - | - | 1件: 96 96 💬
|
| 733 | MSC treatment 01 | - | - | - | - | 1件: 96 96 💬
|
| 734 | MSC treatment 02 | - | - | - | - | 1件: 96 96 💬
|
| 735 | MSC-AFP | - | - | - | - | 1件: 96 96 💬
|
| 736 | MT-1303 | - | - | - | - | 3件: 13 13, 96, 97 💬
|
| 737 | MTP-101C | - | - | - | - | 1件: 96 96 💬
|
| 738 | MTP-101S | - | - | - | - | 1件: 96 96 💬
|
| 739 | MTX | - | - | - | - | 14件: 13 13, 35, 40, 46, 49, 50, 51, 54, 55, 60, 84, 96, 107, 162 💬
|
| 740 | MVA HAV | - | - | - | - | 1件: 96 96 💬
|
| 741 | Mycodigest supplement | - | - | - | - | 2件: 96 96, 97 💬
|
| 742 | Mycophenolate mofetil | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 32件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 46, 49, 51, 53, 60, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
|
| 743 | Mycophenolic acid | 1件: Mycophenolic acid Mycophenolic acid | 2件: Mycophenolate sodium
Mycophenolate sodium
,
Mycophenolic acid
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 8件: 11 11, 43, 49, 51, 60, 66, 96, 222 💬
|
| 744 | N-3 polyunsaturated fatty acids | - | - | - | - | 1件: 96 96 💬
|
| 745 | N-{4-chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamide, sodium | - | - | - | - | 1件: 96 96 💬
|
| 746 | N-{4-chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamidesodium | - | - | - | - | 1件: 96 96 💬
|
| 747 | Naltrexone | 1件: Naltrexone Naltrexone | 2件: Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 6 6, 10, 13, 96, 226 💬
|
| 748 | Naltrexone hydrochloride | 1件: Naltrexone Naltrexone | 2件: Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 9件: 10 10, 40, 41, 42, 43, 44, 45, 96, 97 💬
|
| 749 | Naltrexone-HCL | 1件: Naltrexone Naltrexone | 2件: Naltrexone hydrochloride
Naltrexone hydrochloride
,
Naltrexone
💬
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬
| 7件: Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 96 96 💬
|
| 750 | NAP | - | - | - | - | 2件: 96 96, 240 💬
|
| 751 | Natalizumab | 1件: Natalizumab Natalizumab | 1件: Natalizumab
Natalizumab
💬
| 1件: ITGA4 ITGA4 💬
| 15件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬 | 5件: 13 13, 15, 25, 46, 96 💬
|
| 752 | Neomycin | 1件: Neomycin Neomycin | 3件: Neomycin sulfate
Neomycin sulfate
,
Neomycin palmitate
,
Neomycin
💬
| - | - | 3件: 96 96, 97, 296 💬
|
| 753 | Nessuno | - | - | - | - | 1件: 96 96 💬
|
| 754 | Nitazoxanide | 1件: Nitazoxanide Nitazoxanide | 1件: Nitazoxanide
Nitazoxanide
💬
| - | - | 1件: 96 96 💬
|
| 755 | Nivolumab | 1件: Nivolumab Nivolumab | 1件: Nivolumab
Nivolumab
💬
| 1件: PDCD1 PDCD1 💬
| 3件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | 12件: 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
|
| 756 | NNC 0142-0000-0002 | - | - | - | - | 2件: 46 46, 96 💬
|
| 757 | NNC0114-0006 | 1件: NNC0114-0006 NNC0114-0006 | - | - | - | 3件: 46 46, 49, 96 💬
|
| 758 | NNC0142-0000-0002 | - | - | - | - | 1件: 96 96 💬
|
| 759 | NNC142-0002 | - | - | - | - | 1件: 96 96 💬
|
| 760 | None AT this time | - | - | - | - | 2件: 96 96, 140 💬
|
| 761 | Normal diet | - | - | - | - | 2件: 96 96, 97 💬
|
| 762 | Normal saline | - | - | - | - | 20件: 6 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 97, 210, 211, 222, 226, 276, 280, 296, 299 💬
|
| 763 | Normix*AD 12CPR RIV 200MG | - | - | - | - | 1件: 96 96 💬
|
| 764 | NOW foods L-ornithine capsules | - | - | - | - | 1件: 96 96 💬
|
| 765 | NS | - | - | - | - | 1件: 96 96 💬
|
| 766 | NSP001 | - | - | - | - | 1件: 96 96 💬
|
| 767 | Nutraceutical combination | - | - | - | - | 1件: 96 96 💬
|
| 768 | Nutrition treat | - | - | - | - | 1件: 96 96 💬
|
| 769 | Nutritional dietary intervention | - | - | - | - | 2件: 96 96, 97 💬
|
| 770 | Nutropinaq 10MG/2ML solution FOR injection | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 96 96 💬
|
| 771 | Obefazimod | - | - | - | - | 2件: 96 96, 97 💬
|
| 772 | OD-07656 | - | - | - | - | 3件: 96 96, 97, 110 💬
|
| 773 | OL adalimumab 40 MG | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 774 | Oligofructose enriched inulin | - | - | - | - | 1件: 96 96 💬
|
| 775 | Olokizumab | 1件: Olokizumab Olokizumab | 1件: Olokizumab
Olokizumab
💬
| 1件: IL6 IL6 💬
| 49件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Epstein-Barr virus infection, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Tuberculosis, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection 💬 | 2件: 46 46, 96 💬
|
| 776 | Omega-3 | 1件: Omega-3 fatty acids Omega-3 fatty acids | - | - | - | 3件: 46 46, 49, 96 💬
|
| 777 | Omegaven | 1件: Fish oil Fish oil | - | - | - | 1件: 96 96 💬
|
| 778 | Omeprazol | 1件: Omeprazole Omeprazole | 3件: Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 2件: 96 96, 294 💬
|
| 779 | Omeprazole | 1件: Omeprazole Omeprazole | 3件: Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 12件: 6 6, 13, 21, 46, 85, 90, 96, 97, 98, 271, 282, 298 💬
|
| 780 | Omeprazole 20 MG | 1件: Omeprazole Omeprazole | 3件: Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 2件: 96 96, 97 💬
|
| 781 | Omeprazole 40 MG | 1件: Omeprazole Omeprazole | 3件: Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| 2件: ATP4A ATP4A, ATP4B 💬
| 3件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | 1件: 96 96 💬
|
| 782 | Only 1 ARM: treatment with MSC-AFP | - | - | - | - | 1件: 96 96 💬
|
| 783 | Ontamalimab | 1件: Ontamalimab Ontamalimab | - | - | - | 2件: 96 96, 97 💬
|
| 784 | OPC-6535 | - | - | - | - | 2件: 96 96, 97 💬
|
| 785 | OPS-2071 | - | - | - | - | 1件: 96 96 💬
|
| 786 | OPS-2071 150 MG | - | - | - | - | 1件: 96 96 💬
|
| 787 | OPS-2071 300 MG | - | - | - | - | 1件: 96 96 💬
|
| 788 | OPS-2071 600 MG | - | - | - | - | 1件: 96 96 💬
|
| 789 | Optison | - | - | - | - | 1件: 96 96 💬
|
| 790 | Oral contrast media application | - | - | - | - | 1件: 96 96 💬
|
| 791 | Oral prednisolone | - | - | - | - | 3件: 49 49, 96, 145 💬
|
| 792 | Orencia | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 15件: 44 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 160, 222, 271, 300 💬
|
| 793 | Originator (legacy) drug | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
| 794 | Ossium VBM-MSC | - | - | - | - | 1件: 96 96 💬
|
| 795 | OSSM-001 | 1件: Allogenic bone marrow-derived mesenchymal stem cells Allogenic bone marrow-derived mesenchymal stem cells | - | - | - | 1件: 96 96 💬
|
| 796 | Other biologic agents | - | - | - | - | 2件: 96 96, 97 💬
|
| 797 | Other biologic therapies | - | - | - | - | 2件: 96 96, 97 💬
|
| 798 | Other biological agent | - | - | - | - | 2件: 46 46, 96 💬
|
| 799 | OVA-treg | - | - | - | - | 1件: 96 96 💬
|
| 800 | Ovasave | - | - | - | - | 1件: 96 96 💬
|
| 801 | Oxadrop | - | - | - | - | 1件: 96 96 💬
|
| 802 | Oxygen GAS FOR inhalation | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
💬
| - | - | 2件: 96 96, 97 💬
|
| 803 | Ozanimod | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 13 13, 96, 97 💬
|
| 804 | Ozanimod HCL | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 13 13, 96, 97 💬
|
| 805 | Ozanimod hydrochloride | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 3件: 13 13, 96, 97 💬
|
| 806 | P28GST | - | - | - | - | 1件: 96 96 💬
|
| 807 | Palifermin | 1件: Palifermin Palifermin | 1件: Palifermin
Palifermin
💬
| 1件: FGFR2 FGFR2 💬
| 12件: Calcium signaling pathway Calcium signaling pathway, Central carbon metabolism in cancer, Endocytosis, Gastric cancer, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Signaling pathways regulating pluripotency of stem cells 💬 | 6件: 13 13, 36, 38, 39, 65, 96 💬
|
| 808 | Pancreatin | 1件: Pancrelipase Pancrelipase | 2件: Pancreatin
Pancreatin
,
Pancrelipase
💬
| - | - | 3件: 96 96, 298, 299 💬
|
| 809 | Pancrelipase | 2件: Pancrelipase Pancrelipase, Pancrelipase amylase | 2件: Pancreatin
Pancreatin
,
Pancrelipase
💬
| - | - | 4件: 96 96, 97, 298, 299 💬
|
| 810 | Partial enteral nutrition | - | - | - | - | 3件: 96 96, 97, 271 💬
|
| 811 | Pcdai | - | - | - | - | 1件: 96 96 💬
|
| 812 | PDA001 | - | - | - | - | 2件: 46 46, 96 💬
|
| 813 | Pectin | 1件: Pectin Pectin | 1件: Pectin
Pectin
💬
| - | - | 1件: 96 96 💬
|
| 814 | Pegylated interferon alfa | - | - | - | - | 1件: 96 96 💬
|
| 815 | Pending | - | - | - | - | 7件: 6 6, 13, 19, 96, 97, 113, 302 💬
|
| 816 | Pentasa | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 2件: 96 96, 97 💬
|
| 817 | Pentasa sachet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 2件: 96 96, 97 💬
|
| 818 | Pentasa sachet 1 G prolonged release granules | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 96 96 💬
|
| 819 | Pentoxifylline | 1件: Pentoxifylline Pentoxifylline | 1件: Pentoxifylline
Pentoxifylline
💬
| - | - | 11件: 26 26, 56, 84, 93, 96, 97, 113, 220, 222, 296, 298 💬
|
| 820 | Peptidic+probiotic | - | - | - | - | 1件: 96 96 💬
|
| 821 | Peptison liquid | - | - | - | - | 1件: 96 96 💬
|
| 822 | Peripheral blood stem cell infusion | - | - | - | - | 1件: 96 96 💬
|
| 823 | PF 06687234 | - | - | - | - | 2件: 96 96, 97 💬
|
| 824 | PF-00547659 | - | - | - | - | 2件: 96 96, 97 💬
|
| 825 | PF-00547659 SC injection | - | - | - | - | 2件: 96 96, 97 💬
|
| 826 | PF-04236921 | - | - | - | - | 2件: 49 49, 96 💬
|
| 827 | PF-04236921 SC injection | - | - | - | - | 1件: 96 96 💬
|
| 828 | PF-06651600 | - | - | - | - | 3件: 46 46, 96, 97 💬
|
| 829 | PF-06651600 50 MG | - | - | - | - | 2件: 96 96, 97 💬
|
| 830 | PF-06651600 50MG | - | - | - | - | 1件: 96 96 💬
|
| 831 | PF-06651600-15 | - | - | - | - | 2件: 96 96, 97 💬
|
| 832 | PF-06700841 | 1件: PF-06700841 PF-06700841 | - | - | - | 1件: 96 96 💬
|
| 833 | PF-06700841 25 MG | 1件: PF-06700841 PF-06700841 | - | - | - | 2件: 96 96, 97 💬
|
| 834 | PF-06700841 5 MG | 1件: PF-06700841 PF-06700841 | - | - | - | 2件: 96 96, 97 💬
|
| 835 | PF-06700841-15 | 1件: PF-06700841 PF-06700841 | - | - | - | 3件: 49 49, 96, 97 💬
|
| 836 | PF2020-cell (UC-mscs) - allogeneic human umbilical cord mesenchymal stem cells | - | - | - | - | 1件: 96 96 💬
|
| 837 | PGX-guided POST-operative pain management | - | - | - | - | 2件: 96 96, 97 💬
|
| 838 | Pharmacokinetics OF certolizumab pegol | - | - | - | - | 2件: 46 46, 96 💬
|
| 839 | Phase1 : cded/modulen™IBD® + maintenance therapy | - | - | - | - | 1件: 96 96 💬
|
| 840 | Phylloquinone | 1件: Phylloquinone Phylloquinone | 1件: Phytonadione
Phytonadione
💬
| - | - | 1件: 96 96 💬
|
| 841 | Physician standard-OF-care | - | - | - | - | 1件: 96 96 💬
|
| 842 | Pioglitazone 15 MG | 1件: Pioglitazone Pioglitazone | 2件: Pioglitazone hydrochloride
Pioglitazone hydrochloride
,
Pioglitazone
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 96 96 💬
|
| 843 | PK-model TO decide when TO dose vedolizumab and ustekinumab | - | - | - | - | 2件: 96 96, 97 💬
|
| 844 | PL 17901/0122 | - | - | - | - | 1件: 96 96 💬
|
| 845 | PL 20532/0012 | - | - | - | - | 1件: 96 96 💬
|
| 846 | Plantain NSP | - | - | - | - | 1件: 96 96 💬
|
| 847 | Plaquenil | 1件: Hydroxychloroquine Hydroxychloroquine | 2件: Hydroxychloroquine sulfate
Hydroxychloroquine sulfate
,
Hydroxychloroquine
💬
| - | - | 5件: 46 46, 49, 53, 84, 96 💬
|
| 848 | Pnemovax | - | - | - | - | 1件: 96 96 💬
|
| 849 | Pneumovax | - | - | - | - | 4件: 46 46, 49, 96, 97 💬
|
| 850 | Polaprezinc | 1件: Polaprezinc Polaprezinc | 1件: Polaprezinc
Polaprezinc
💬
| - | - | 2件: 96 96, 97 💬
|
| 851 | Polyethylene glycol 3350 | 1件: Polyethylene glycol Polyethylene glycol | 3件: Polyethylene glycol 3350
Polyethylene glycol 3350
,
Macrogol 4000
,
Macrogol 6000
💬
| - | - | 2件: 96 96, 299 💬
|
| 852 | Polyethylene glycol preparation | 1件: Polyethylene glycol Polyethylene glycol | 3件: Polyethylene glycol 3350
Polyethylene glycol 3350
,
Macrogol 4000
,
Macrogol 6000
💬
| - | - | 1件: 96 96 💬
|
| 853 | Posaconazole delayed release oral tablet | 1件: Posaconazole Posaconazole | 1件: Posaconazole
Posaconazole
💬
| - | - | 1件: 96 96 💬
|
| 854 | Positron emission tomography | - | - | - | - | 6件: 26 26, 28, 40, 46, 49, 96 💬
|
| 855 | Postoperative 3-month exclusive enteral nutrition | - | - | - | - | 1件: 96 96 💬
|
| 856 | PRA023 | - | - | - | - | 3件: 51 51, 96, 97 💬
|
| 857 | PRA023 IV | - | - | - | - | 1件: 96 96 💬
|
| 858 | Pravastatin | 1件: Pravastatin Pravastatin | 2件: Pravastatin sodium
Pravastatin sodium
,
Pravastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 10件: 13 13, 46, 49, 67, 79, 96, 164, 210, 265, 333 💬
|
| 859 | PRE-filled syringe | - | - | - | - | 7件: 46 46, 49, 53, 96, 97, 107, 271 💬
|
| 860 | Prebiotic | - | - | - | - | 2件: 96 96, 97 💬
|
| 861 | Prebiotics | - | - | - | - | 2件: 96 96, 97 💬
|
| 862 | Precedentemente denominato MEDI2070 E AMG 139 | - | - | - | - | 1件: 96 96 💬
|
| 863 | Precision dosing with A dashboard | - | - | - | - | 1件: 96 96 💬
|
| 864 | Prednisolon | - | - | - | - | 7件: 46 46, 51, 66, 95, 96, 97, 251 💬
|
| 865 | Prednisolon jenapharm | - | - | - | - | 2件: 96 96, 97 💬
|
| 866 | Prednisolone | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 38件: 3 3, 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 54, 56, 60, 63, 64, 66, 81, 84, 85, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
|
| 867 | Prednisone | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 54件: 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
|
| 868 | Prednisone/methylprenisolone | 1件: Prednisone Prednisone | 1件: Prednisone
Prednisone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 💬
|
| 869 | Preparative regimen 4-6 weeks after leukapheresis | - | - | - | - | 1件: 96 96 💬
|
| 870 | Prevenar 13 | - | - | - | - | 4件: 13 13, 46, 96, 97 💬
|
| 871 | Previously referred TO AS MEDI2070 and AMG 139, AGN-151-598 | - | - | - | - | 1件: 96 96 💬
|
| 872 | Probiotic | 1件: Lactobacillus acidophilus Lactobacillus acidophilus | 1件: Lactomin
Lactomin
💬
| - | - | 9件: 2 2, 6, 93, 96, 97, 127, 193, 266, 299 💬
|
| 873 | Probiotic - VSL#3 | - | - | - | - | 2件: 96 96, 97 💬
|
| 874 | Probiotic mixture | - | - | - | - | 2件: 96 96, 97 💬
|
| 875 | Probiotics | - | - | - | - | 6件: 6 6, 94, 96, 97, 206, 291 💬
|
| 876 | Prochymal adult human mesenchymal stem cells | 1件: Remestemcel-L Remestemcel-L | 1件: Remestemcel-L
Remestemcel-L
💬
| - | - | 1件: 96 96 💬
|
| 877 | Prochymal™ adult human mesenchymal stem cells | 1件: Remestemcel-L Remestemcel-L | 1件: Remestemcel-L
Remestemcel-L
💬
| - | - | 1件: 96 96 💬
|
| 878 | Promethazine | 1件: Promethazine Promethazine | 3件: Promethazine hydrochloride
Promethazine hydrochloride
,
Promethazine
,
Promethazine teoclate
💬
| 1件: HRH1 HRH1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | 2件: 6 6, 96 💬
|
| 879 | Prucalopride | 1件: Prucalopride Prucalopride | 2件: Prucalopride
Prucalopride
,
Prucalopride succinate
💬
| 1件: HTR4 HTR4 💬
| 5件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬 | 2件: 13 13, 96 💬
|
| 880 | PRV-6527 | - | - | - | - | 1件: 96 96 💬
|
| 881 | PTG-200 | - | - | - | - | 1件: 96 96 💬
|
| 882 | Puri nethol | - | - | - | - | 2件: 96 96, 97 💬
|
| 883 | PURI-nethol | - | - | - | - | 3件: 86 86, 96, 97 💬
|
| 884 | PURI-nethol 50 MG | - | - | - | - | 1件: 96 96 💬
|
| 885 | Purinethol | 1件: Mercaptopurine Mercaptopurine | 2件: Mercaptopurine
Mercaptopurine
,
Mercaptopurine
💬
| 1件: hprT hprT 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 1件: 96 96 💬
|
| 886 | Purinethol - 50 MG compresse25 compresse | - | - | - | - | 1件: 96 96 💬
|
| 887 | QAX567 | - | - | - | - | 1件: 96 96 💬
|
| 888 | QAX576 | - | - | - | - | 4件: 51 51, 85, 96, 98 💬
|
| 889 | Qbeco | - | - | - | - | 2件: 96 96, 97 💬
|
| 890 | Qbeco-SSI | - | - | - | - | 1件: 96 96 💬
|
| 891 | Quality-OF-life assessment | - | - | - | - | 11件: 28 28, 34, 36, 51, 62, 63, 65, 96, 284, 286, 298 💬
|
| 892 | Questionnaires | - | - | - | - | 7件: 3 3, 6, 13, 28, 41, 49, 96 💬
|
| 893 | Rabbit | 1件: Rabbit Rabbit | - | - | - | 5件: 11 11, 13, 60, 96, 285 💬
|
| 894 | Rabbit ANTI-human thymocyte immunoglobulin | 2件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Rabbit | 1件: Anti-human thymocyte immunoglobulin, rabbit
Anti-human thymocyte immunoglobulin, rabbit
💬
| 11件: CD2 CD2, CD3D, CD3E, CD3G, CD4, CD5, CD7, CD8A, CD8B, IL2RA, ITGAL 💬
| 31件: Antigen processing and presentation Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬 | 2件: 13 13, 96 💬
|
| 895 | Rabbit antithymocyte globulin | 2件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit), Rabbit | 1件: Anti-human thymocyte immunoglobulin, rabbit
Anti-human thymocyte immunoglobulin, rabbit
💬
| 11件: CD2 CD2, CD3D, CD3E, CD3G, CD4, CD5, CD7, CD8A, CD8B, IL2RA, ITGAL 💬
| 31件: Antigen processing and presentation Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬 | 3件: 49 49, 60, 96 💬
|
| 896 | RAD001 | - | - | - | - | 6件: 34 34, 67, 89, 96, 158, 228 💬
|
| 897 | Radiotracer injection | - | - | - | - | 2件: 94 94, 96 💬
|
| 898 | Ranolazine | 1件: Ranolazine Ranolazine | 2件: Ranolazine
Ranolazine
,
Ranolazine hydrochloride
💬
| - | - | 7件: 2 2, 58, 86, 96, 97, 113, 114 💬
|
| 899 | Rapamycin | 1件: Sirolimus Sirolimus | 1件: Sirolimus
Sirolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 19件: 2 2, 15, 34, 35, 46, 49, 51, 53, 60, 61, 63, 67, 86, 96, 158, 193, 256, 279, 283 💬
|
| 900 | Raptiva 100 MG/ML powder and solvent FOR solution FOR injection | 1件: Efalizumab Efalizumab | 1件: Efalizumab
Efalizumab
💬
| 1件: ITGAL ITGAL 💬
| 12件: Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis 💬 | 8件: 11 11, 13, 46, 53, 61, 95, 96, 221 💬
|
| 901 | Rbatg | - | - | - | - | 2件: 51 51, 96 💬
|
| 902 | RCTB-401 | - | - | - | - | 2件: 96 96, 97 💬
|
| 903 | Received hormone maintenance therapy | - | - | - | - | 1件: 96 96 💬
|
| 904 | Recombinant growth hormone | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 1件: 96 96 💬
|
| 905 | Recombinant human insulin-like growth factor | - | - | - | - | 1件: 96 96 💬
|
| 906 | Remestemcel-L | 1件: Remestemcel-L Remestemcel-L | 1件: Remestemcel-L
Remestemcel-L
💬
| - | - | 2件: 96 96, 97 💬
|
| 907 | Remicade | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 8件: 46 46, 49, 56, 84, 85, 96, 97, 271 💬
|
| 908 | Remicade 100 MG | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 56 56, 96, 97 💬
|
| 909 | Remicade 100 MG pulver TIL konsentrat TIL infusjonsvæSKE, oppløsning | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
| 910 | Remisma | - | - | - | - | 1件: 96 96 💬
|
| 911 | Remsima | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 4件: 46 46, 96, 97, 271 💬
|
| 912 | Remsima 100 MG powder FOR solution FOR infusion | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 913 | Remsima 100 MG pulver TIL konsentrat TIL infusjonsvæSKE, oppløsning | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
| 914 | Remsima 120 MG solution FOR injection IN PRE-filled syringe | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 915 | Remsima and inflectra | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
| 916 | Remsina | - | - | - | - | 1件: 96 96 💬
|
| 917 | RHB-104 | - | - | - | - | 2件: 13 13, 96 💬
|
| 918 | Rhgh | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 5件: 76 76, 96, 193, 246, 337 💬
|
| 919 | RHIL-11 | - | - | - | - | 2件: 96 96, 97 💬
|
| 920 | Ribavirin | 1件: Ribavirin Ribavirin | 1件: Ribavirin
Ribavirin
💬
| - | - | 2件: 2 2, 96 💬
|
| 921 | Riboflavin sodium phosphate injection | 1件: Riboflavin Riboflavin | 1件: Riboflavin
Riboflavin
💬
| - | - | 1件: 96 96 💬
|
| 922 | Riboflavin supplementation | 1件: Riboflavin Riboflavin | 1件: Riboflavin
Riboflavin
💬
| - | - | 1件: 96 96 💬
|
| 923 | Rifabutin | 1件: Rifabutin Rifabutin | 1件: Rifabutin
Rifabutin
💬
| - | - | 1件: 96 96 💬
|
| 924 | Rifabutin, clarithromycin, and clofazimine | 1件: Rifabutin Rifabutin | 1件: Rifabutin
Rifabutin
💬
| - | - | 1件: 96 96 💬
|
| 925 | Rifaximin | 1件: Rifaximin Rifaximin | 1件: Rifaximin
Rifaximin
💬
| - | - | 8件: 6 6, 65, 93, 96, 97, 99, 296, 299 💬
|
| 926 | Rifaximin delayed release 400 MG film coated tablet | 1件: Rifaximin Rifaximin | 1件: Rifaximin
Rifaximin
💬
| - | - | 1件: 96 96 💬
|
| 927 | Rifaximin delayed release tablets | 1件: Rifaximin Rifaximin | 1件: Rifaximin
Rifaximin
💬
| - | - | 1件: 96 96 💬
|
| 928 | Rifaximin EIR | 1件: Rifaximin Rifaximin | 1件: Rifaximin
Rifaximin
💬
| - | - | 1件: 96 96 💬
|
| 929 | Rifaximin+omeprazole+miralax | 1件: Rifaximin Rifaximin | 1件: Rifaximin
Rifaximin
💬
| - | - | 1件: 96 96 💬
|
| 930 | Rifaximin-EIR | 1件: Rifaximin Rifaximin | 1件: Rifaximin
Rifaximin
💬
| - | - | 1件: 96 96 💬
|
| 931 | Rifaximina | 1件: Rifaximin Rifaximin | 1件: Rifaximin
Rifaximin
💬
| - | - | 1件: 96 96 💬
|
| 932 | Risankizumab | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 4件: 37 37, 96, 97, 271 💬
|
| 933 | Risankizumab 10 MG/ML | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 96 96 💬
|
| 934 | Risankizumab 180 MG SC | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 96 96 💬
|
| 935 | Risankizumab 600 MG IV | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 96 96 💬
|
| 936 | Risankizumab 90 MG/ML | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 1件: 96 96 💬
|
| 937 | Risankizumab IV | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
| 938 | Risankizumab SC | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
| 939 | Risankizumab-800CW 15 MG | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
| 940 | Risankizumab-800CW 25 MG | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
| 941 | Risankizumab-800CW 4.5 MG | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
| 942 | Risankizumab-800CW optimal dose | 1件: Risankizumab Risankizumab | 1件: Risankizumab
Risankizumab
💬
| 1件: IL23A IL23A 💬
| 9件: C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | 2件: 96 96, 97 💬
|
| 943 | Risedronate | 1件: Risedronic acid Risedronic acid | 3件: Risedronate sodium
Risedronate sodium
,
Risedronic acid
,
Risedronate sodium monohydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 3件: 46 46, 66, 96 💬
|
| 944 | Ritlecitinib 50 MG | 1件: Ritlecitinib Ritlecitinib | 1件: Ritlecitinib tosylate
Ritlecitinib tosylate
💬
| 1件: JAK3 JAK3 💬
| 15件: Chemokine signaling pathway Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬 | 2件: 96 96, 97 💬
|
| 945 | Ritlecitinib 50MG | 1件: Ritlecitinib Ritlecitinib | 1件: Ritlecitinib tosylate
Ritlecitinib tosylate
💬
| 1件: JAK3 JAK3 💬
| 15件: Chemokine signaling pathway Chemokine signaling pathway, Epstein-Barr virus infection, Hepatitis B, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, Necroptosis, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral carcinogenesis 💬 | 1件: 96 96 💬
|
| 946 | Rituximab | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 52件: 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
| 947 | Rizankisumab | - | - | - | - | 1件: 96 96 💬
|
| 948 | Rizankizumab | - | - | - | - | 1件: 96 96 💬
|
| 949 | RO 549-0261/F04-02 | - | - | - | - | 1件: 96 96 💬
|
| 950 | RO 549-0261/F08-02 | - | - | - | - | 1件: 96 96 💬
|
| 951 | RO549-0261/F04-02 | - | - | - | - | 1件: 96 96 💬
|
| 952 | RO5490261/F02 | - | - | - | - | 2件: 96 96, 97 💬
|
| 953 | RO7790121 | - | - | - | - | 2件: 96 96, 97 💬
|
| 954 | Roadmab | - | - | - | - | 1件: 96 96 💬
|
| 955 | Rosuvastatin | 1件: Rosuvastatin Rosuvastatin | 2件: Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 9件: 6 6, 18, 46, 49, 51, 79, 94, 96, 271 💬
|
| 956 | Rosuvastatin 10 MG | 1件: Rosuvastatin Rosuvastatin | 2件: Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 96 96 💬
|
| 957 | Routine drainage surgery | - | - | - | - | 1件: 96 96 💬
|
| 958 | Routine treatment OF CD | - | - | - | - | 1件: 96 96 💬
|
| 959 | RPC0163 | - | - | - | - | 1件: 96 96 💬
|
| 960 | RPC1063 | - | - | - | - | 3件: 13 13, 96, 97 💬
|
| 961 | RPC1063 (equivalent TO ozanimod | 1件: Ozanimod Ozanimod | 2件: Ozanimod hydrochloride
Ozanimod hydrochloride
,
Ozanimod
💬
| 5件: S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 96 96 💬
|
| 962 | RVG 05565 | - | - | - | - | 1件: 96 96 💬
|
| 963 | RVG 07151 | - | - | - | - | 1件: 96 96 💬
|
| 964 | RVG 114681 | - | - | - | - | 2件: 96 96, 97 💬
|
| 965 | RVG 116648 | - | - | - | - | 2件: 96 96, 97 💬
|
| 966 | RVG00859 | - | - | - | - | 2件: 96 96, 97 💬
|
| 967 | RVT-3101 | 1件: RVT-3101 RVT-3101 | - | - | - | 1件: 96 96 💬
|
| 968 | RYAH-medtech inhaler | - | - | - | - | 5件: 2 2, 6, 13, 96, 97 💬
|
| 969 | Saline | 1件: Sodium chloride Sodium chloride | 1件: Sodium chloride
Sodium chloride
💬
| - | - | 19件: 2 2, 6, 13, 17, 18, 46, 53, 67, 77, 86, 96, 97, 98, 168, 256, 271, 274, 299, 301 💬
|
| 970 | Salmon | 1件: Salmon, unspecified Salmon, unspecified | - | - | - | 3件: 96 96, 97, 225 💬
|
| 971 | Salofalk | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 2件: 96 96, 97 💬
|
| 972 | Salofalk 500 MG | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 96 96 💬
|
| 973 | Sandostatine | - | - | - | - | 1件: 96 96 💬
|
| 974 | SAR441566 | - | - | - | - | 3件: 46 46, 96, 97 💬
|
| 975 | Sargramostim | 1件: Sargramostim Sargramostim | 1件: Sargramostim
Sargramostim
💬
| 1件: CSF2RA CSF2RA 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 7件: 6 6, 28, 60, 62, 96, 229, 285 💬
|
| 976 | SB5 | - | - | - | - | 5件: 46 46, 96, 97, 107, 271 💬
|
| 977 | SC tulisokibart | - | - | - | - | 2件: 96 96, 97 💬
|
| 978 | SC12267 | 1件: SC12267 SC12267 | - | - | - | 3件: 46 46, 96, 97 💬
|
| 979 | Search FOR exocrine pancreatic insufficiency AT week 0 and 12 | - | - | - | - | 1件: 96 96 💬
|
| 980 | Selective immunosuppressive agents | - | - | - | - | 1件: 96 96 💬
|
| 981 | Selective intensive induction therapy based ON ustekinumab clinical decision-making tools | - | - | - | - | 1件: 96 96 💬
|
| 982 | Selenium | 1件: Selenium Selenium | - | - | - | 4件: 13 13, 96, 278, 298 💬
|
| 983 | Semapimod | 1件: Semapimod Semapimod | - | - | - | 1件: 96 96 💬
|
| 984 | Serum leucine-rich alpha-2 glycoprotein (LRG) levels | - | - | - | - | 2件: 96 96, 97 💬
|
| 985 | Seton placement | - | - | - | - | 1件: 96 96 💬
|
| 986 | Sezione * D.3.6.2.1 - valore: 400MG alla settimana 0, IN seguito 200MG ogni DUE settimane | - | - | - | - | 1件: 96 96 💬
|
| 987 | Shingrix | - | - | - | - | 4件: 46 46, 49, 96, 97 💬
|
| 988 | SHP647 | - | - | - | - | 2件: 96 96, 97 💬
|
| 989 | SHR0302 | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
| 990 | Sibofimloc | 1件: Sibofimloc Sibofimloc | 1件: Sibofimloc
Sibofimloc
💬
| - | - | 1件: 96 96 💬
|
| 991 | Simethicone | 1件: Simethicone Simethicone | 1件: Simethicone
Simethicone
💬
| - | - | 2件: 13 13, 96 💬
|
| 992 | Sivelestat | 1件: Sivelestat Sivelestat | 1件: Sivelestat
Sivelestat
💬
| 1件: ELANE ELANE 💬
| 3件: Neutrophil extracellular trap formation Neutrophil extracellular trap formation, Systemic lupus erythematosus, Transcriptional misregulation in cancer 💬 | 3件: 13 13, 85, 96 💬
|
| 993 | Small bowel follow trough | - | - | - | - | 1件: 96 96 💬
|
| 994 | Smoflipid | - | - | - | - | 1件: 96 96 💬
|
| 995 | Smoking cigarettes | - | - | - | - | 2件: 96 96, 97 💬
|
| 996 | Smoking OF cannabis | - | - | - | - | 2件: 96 96, 97 💬
|
| 997 | SOC corticosteroid - induction period | - | - | - | - | 1件: 96 96 💬
|
| 998 | SOC corticosteroid - tapering | - | - | - | - | 1件: 96 96 💬
|
| 999 | Sodium chloride | 1件: Sodium chloride Sodium chloride | 1件: Sodium chloride
Sodium chloride
💬
| - | - | 20件: 2 2, 11, 13, 14, 34, 41, 46, 51, 53, 60, 67, 70, 96, 97, 193, 214, 215, 227, 288, 299 💬
|
| 1000 | Solid FOOD-based intervention | - | - | - | - | 1件: 96 96 💬
|
| 1001 | Somatropin | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 18件: 2 2, 3, 19, 74, 75, 78, 96, 97, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299 💬
|
| 1002 | Somatropin [rdna origin] FOR injection | 1件: Somatotropin Somatotropin | 1件: Somatropin
Somatropin
💬
| 1件: GHR GHR 💬
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 2件: 46 46, 96 💬
|
| 1003 | Sonovue | 1件: Sulfur hexafluoride Sulfur hexafluoride | 1件: Sulfur hexafluoride
Sulfur hexafluoride
💬
| - | - | 2件: 96 96, 97 💬
|
| 1004 | SOY protein | - | - | - | - | 2件: 6 6, 96 💬
|
| 1005 | Soya bean OIL | - | - | - | - | 1件: 96 96 💬
|
| 1006 | Spesolilmab | - | - | - | - | 1件: 96 96 💬
|
| 1007 | Spesolimab | 1件: Spesolimab Spesolimab | 1件: Spesolimab
Spesolimab
💬
| 1件: IL1RL2 IL1RL2 💬
| 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 5件: 37 37, 96, 97, 160, 269 💬
|
| 1008 | ST10 | - | - | - | - | 2件: 96 96, 97 💬
|
| 1009 | ST10-021 | - | - | - | - | 2件: 96 96, 97 💬
|
| 1010 | STA-5326 | - | - | - | - | 2件: 65 65, 96 💬
|
| 1011 | STA-5326 mesylate | - | - | - | - | 1件: 96 96 💬
|
| 1012 | STA-6838, STA-5326 M, S38 | - | - | - | - | 1件: 96 96 💬
|
| 1013 | Stable isotope infusions | - | - | - | - | 1件: 96 96 💬
|
| 1014 | Standard 2 hours-infusion | - | - | - | - | 2件: 96 96, 97 💬
|
| 1015 | Standard clear liquid diet | - | - | - | - | 1件: 96 96 💬
|
| 1016 | Standard infliximab intravenous therapy | - | - | - | - | 1件: 96 96 💬
|
| 1017 | Standard nutrition | - | - | - | - | 1件: 96 96 💬
|
| 1018 | Standard OF care treatment | - | - | - | - | 4件: 53 53, 96, 245, 246 💬
|
| 1019 | Standard STEP-UP care | - | - | - | - | 1件: 96 96 💬
|
| 1020 | Standart OF care | - | - | - | - | 1件: 96 96 💬
|
| 1021 | Start adalimumab IN monotherapy | - | - | - | - | 1件: 96 96 💬
|
| 1022 | Stelara | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 6件: 49 49, 56, 96, 97, 269, 271 💬
|
| 1023 | Stelara - 45 MG soluzione iniettabile - USO sottocutaneo - flaconcino (vetro) 0.5 ML (90 MG/ML) 1 flaconcino | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 96 96, 97 💬
|
| 1024 | Stelara - 90 MG - soluzione iniettabile IN siringhe preriempite - USO sottocutaneo - siringa preriempita(vetro) 1 ML(90MG/ML) 1 siringa preriempita DA 1 ML | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 96 96, 97 💬
|
| 1025 | Stelara - 90 MG soluzione iniettabile - USO sottocutaneo - flaconcino (vetro) 1.0 ML (90 MG/ML) 1 flaconcino | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 2件: 96 96, 97 💬
|
| 1026 | Stelara 130 MG concentrate FOR solution FOR infusion | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 96 96 💬
|
| 1027 | Stelara 130MG / 26ML concentrate FOR solution FOR infusion | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 96 96 💬
|
| 1028 | Stelara 45 MG solution FOR injection | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 96 96 💬
|
| 1029 | Stelara 90 MG solution FOR injection IN PRE-filled syringe | 1件: Ustekinumab Ustekinumab | 1件: Ustekinumab
Ustekinumab
💬
| 3件: IL12A IL12A, IL12B, IL23A 💬
| 28件: African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | 1件: 96 96 💬
|
| 1030 | Stelara 90 MG solution FOR injection N PRE-filled syringue | - | - | - | - | 1件: 96 96 💬
|
| 1031 | Stelara, remicade, entyvio, humira, remsima, flixabi, inflectra | - | - | - | - | 1件: 96 96 💬
|
| 1032 | Stelara® | - | - | - | - | 2件: 96 96, 97 💬
|
| 1033 | Stem cell transplant | - | - | - | - | 7件: 19 19, 20, 60, 65, 96, 164, 284 💬
|
| 1034 | Stem cells | - | - | - | - | 5件: 2 2, 4, 46, 96, 113 💬
|
| 1035 | STEP-UP | - | - | - | - | 1件: 96 96 💬
|
| 1036 | Steroids | - | - | - | - | 6件: 46 46, 50, 51, 63, 96, 97 💬
|
| 1037 | Stool simple | - | - | - | - | 1件: 96 96 💬
|
| 1038 | SUB20016 | - | - | - | - | 2件: 96 96, 97 💬
|
| 1039 | Sugar extract | - | - | - | - | 2件: 96 96, 97 💬
|
| 1040 | Sulfur hexafluoride | 1件: Sulfur hexafluoride Sulfur hexafluoride | 1件: Sulfur hexafluoride
Sulfur hexafluoride
💬
| - | - | 3件: 96 96, 97, 215 💬
|
| 1041 | Sulphur hexafluoride | 1件: Sulfur hexafluoride Sulfur hexafluoride | 1件: Sulfur hexafluoride
Sulfur hexafluoride
💬
| - | - | 2件: 96 96, 97 💬
|
| 1042 | Surgery | - | - | - | - | 2件: 74 74, 96 💬
|
| 1043 | Suspension containing 250 embryonated, viable trichuris suis OVA (TSO)/15ML | - | - | - | - | 1件: 96 96 💬
|
| 1044 | Suspension containing 250 embryonated, viable TSO/15ML | - | - | - | - | 1件: 96 96 💬
|
| 1045 | Suspension containing 2500 embryonated, viable trichuris suis OVA (TSO)/15ML | - | - | - | - | 1件: 96 96 💬
|
| 1046 | Suspension containing 2500 embryonated, viable TSO/15ML | - | - | - | - | 1件: 96 96 💬
|
| 1047 | Suspension containing 7500 embryonated, viable trichuris suis OVA (TSO)/15ML | - | - | - | - | 1件: 96 96 💬
|
| 1048 | Suspension OF 7500 embryonated, viable TSO/15ML | - | - | - | - | 1件: 96 96 💬
|
| 1049 | Suspension OF adipose derived autologous adult stem cells | - | - | - | - | 2件: 96 96, 97 💬
|
| 1050 | Synbiotic | - | - | - | - | 1件: 96 96 💬
|
| 1051 | TA-650 | - | - | - | - | 4件: 37 37, 56, 96, 97 💬
|
| 1052 | Tacrolimus | 1件: Tacrolimus Tacrolimus | 2件: Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 31件: 2 2, 6, 11, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 234, 283, 284, 285, 286 💬
|
| 1053 | TAK-018 | - | - | - | - | 1件: 96 96 💬
|
| 1054 | TAK-279 | - | - | - | - | 3件: 37 37, 96, 97 💬
|
| 1055 | Tamibarotene | 1件: Tamibarotene Tamibarotene | 1件: Tamibarotene
Tamibarotene
💬
| 1件: RARA RARA 💬
| 5件: Acute myeloid leukemia Acute myeloid leukemia, Estrogen signaling pathway, Pathways in cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 3件: 26 26, 67, 96 💬
|
| 1056 | Tasty&healthy intervention group | - | - | - | - | 1件: 96 96 💬
|
| 1057 | TBC | - | - | - | - | 4件: 85 85, 94, 96, 127 💬
|
| 1058 | TD-1473 | - | - | - | - | 2件: 96 96, 97 💬
|
| 1059 | TDM-based infliximab intravenous therapy | - | - | - | - | 1件: 96 96 💬
|
| 1060 | Teduglutide | 1件: Teduglutide Teduglutide | 1件: Teduglutide
Teduglutide
💬
| 1件: GLP2R GLP2R 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 💬
|
| 1061 | Teduglutide 0.05 dose | 1件: Teduglutide Teduglutide | 1件: Teduglutide
Teduglutide
💬
| 1件: GLP2R GLP2R 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 💬
|
| 1062 | Teduglutide 0.1 MG dose | 1件: Teduglutide Teduglutide | 1件: Teduglutide
Teduglutide
💬
| 1件: GLP2R GLP2R 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 💬
|
| 1063 | Teduglutide 0.2 MG | 1件: Teduglutide Teduglutide | 1件: Teduglutide
Teduglutide
💬
| 1件: GLP2R GLP2R 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 96 96 💬
|
| 1064 | Terbinafine | 1件: Terbinafine Terbinafine | 2件: Terbinafine hydrochloride
Terbinafine hydrochloride
,
Terbinafine
💬
| - | - | 2件: 96 96, 97 💬
|
| 1065 | Tetomilast | 1件: Tetomilast Tetomilast | - | - | - | 2件: 96 96, 97 💬
|
| 1066 | TEV-48574 | - | - | - | - | 2件: 96 96, 97 💬
|
| 1067 | TEV-48574 dose regimen A | - | - | - | - | 2件: 96 96, 97 💬
|
| 1068 | TEV-48574 dose regiment B | - | - | - | - | 2件: 96 96, 97 💬
|
| 1069 | TH-SC01 | - | - | - | - | 1件: 96 96 💬
|
| 1070 | Thalidomide | 1件: Thalidomide Thalidomide | 1件: Thalidomide
Thalidomide
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 20件: 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300 💬
|
| 1071 | Thalidomide celgene - 50 MG capsula rigida - USO orale - blister (PVC/PE/aclar/ALU) 28 capsule | 1件: Thalidomide Thalidomide | 1件: Thalidomide
Thalidomide
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
| 1072 | Thalidomide pharmion | 1件: Thalidomide Thalidomide | 1件: Thalidomide
Thalidomide
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 3件: 85 85, 96, 97 💬
|
| 1073 | THC 5MG/ML and CBS 50MG/ML | - | - | - | - | 1件: 96 96 💬
|
| 1074 | THE investigational medicinal product (IMP) will BE labeled AS PF-04236921 106 MG/vial, clonal SC lyophilized form, which IS equivalent TO PF-04236921 powder FOR injection, 106 MG/vial AS described IN THE enclosed CTA | - | - | - | - | 1件: 96 96 💬
|
| 1075 | Thetanix | - | - | - | - | 1件: 96 96 💬
|
| 1076 | Thiopurine | - | - | - | - | 2件: 96 96, 97 💬
|
| 1077 | Thiosix | - | - | - | - | 2件: 96 96, 97 💬
|
| 1078 | Thiotepa | 1件: Thiotepa Thiotepa | 1件: Thiotepa
Thiotepa
💬
| - | - | 11件: 13 13, 28, 46, 51, 60, 65, 85, 96, 107, 284, 285 💬
|
| 1079 | Threonine | 1件: Threonine Threonine | 1件: Threonine
Threonine
💬
| - | - | 3件: 86 86, 96, 97 💬
|
| 1080 | THRX-139060 | - | - | - | - | 2件: 96 96, 97 💬
|
| 1081 | Thymoglobulin | 1件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | 1件: Anti-human thymocyte immunoglobulin, rabbit
Anti-human thymocyte immunoglobulin, rabbit
💬
| 11件: CD2 CD2, CD3D, CD3E, CD3G, CD4, CD5, CD7, CD8A, CD8B, IL2RA, ITGAL 💬
| 31件: Antigen processing and presentation Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬 | 6件: 36 36, 51, 60, 96, 285, 326 💬
|
| 1082 | Thymoglobuline | 1件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | 1件: Anti-human thymocyte immunoglobulin, rabbit
Anti-human thymocyte immunoglobulin, rabbit
💬
| 11件: CD2 CD2, CD3D, CD3E, CD3G, CD4, CD5, CD7, CD8A, CD8B, IL2RA, ITGAL 💬
| 31件: Antigen processing and presentation Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬 | 5件: 13 13, 36, 51, 60, 96 💬
|
| 1083 | Ticilimumab | 1件: Tremelimumab Tremelimumab | 1件: Tremelimumab
Tremelimumab
💬
| 1件: CTLA4 CTLA4 💬
| 4件: Autoimmune thyroid disease Autoimmune thyroid disease, Cell adhesion molecules, Rheumatoid arthritis, T cell receptor signaling pathway 💬 | 1件: 96 96 💬
|
| 1084 | Time and attention + active fructooligosaccharide supplementation | - | - | - | - | 2件: 96 96, 97 💬
|
| 1085 | Tirzepatide | 1件: Tirzepatide Tirzepatide | 1件: Tirzepatide
Tirzepatide
💬
| 2件: GIPR GIPR, GLP1R 💬
| 4件: Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 5件: 67 67, 96, 97, 193, 233 💬
|
| 1086 | TNF kinoid | - | - | - | - | 2件: 46 46, 96 💬
|
| 1087 | TNF-alpha antagonists | - | - | - | - | 3件: 46 46, 96, 271 💬
|
| 1088 | TNF-K | - | - | - | - | 2件: 46 46, 96 💬
|
| 1089 | TNF-kinoid | - | - | - | - | 2件: 46 46, 96 💬
|
| 1090 | Tnfa antagonist - adalimumab | - | - | - | - | 1件: 96 96 💬
|
| 1091 | Tnfa antagonist - infliximab | - | - | - | - | 1件: 96 96 💬
|
| 1092 | Tnfa kinoid | - | - | - | - | 2件: 46 46, 96 💬
|
| 1093 | TNFA-kinoid | - | - | - | - | 1件: 96 96 💬
|
| 1094 | TO BE determined | - | - | - | - | 2件: 96 96, 113 💬
|
| 1095 | TO BE requested | - | - | - | - | 2件: 96 96, 97 💬
|
| 1096 | Tofacitinib | 1件: Tofacitinib Tofacitinib | 2件: Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| 4件: JAK1 JAK1, JAK2, JAK3, TYK2 💬
| 39件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 19件: 35 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 65, 66, 96, 97, 107, 110, 162, 271, 300 💬
|
| 1097 | Tolerogenic dendritic cells | - | - | - | - | 2件: 46 46, 96 💬
|
| 1098 | TOP down treatment IF patient AT high risk | - | - | - | - | 2件: 96 96, 97 💬
|
| 1099 | TOP-down | - | - | - | - | 1件: 96 96 💬
|
| 1100 | Total body irradiation | - | - | - | - | 13件: 19 19, 20, 36, 49, 51, 60, 62, 65, 96, 222, 283, 284, 285 💬
|
| 1101 | Total-body irradiation | - | - | - | - | 9件: 28 28, 51, 60, 62, 65, 96, 283, 284, 285 💬
|
| 1102 | Tpmt genotyping | - | - | - | - | 2件: 96 96, 97 💬
|
| 1103 | TQH3906 capsules | - | - | - | - | 2件: 96 96, 97 💬
|
| 1104 | Transfusion | - | - | - | - | 1件: 96 96 💬
|
| 1105 | Treatment according TO current standards without knowledge OF serum infliximab and ANTI-infliximab AB status | - | - | - | - | 1件: 96 96 💬
|
| 1106 | Treatment with adalimumab | - | - | - | - | 1件: 96 96 💬
|
| 1107 | Triamcinolone | 1件: Triamcinolone Triamcinolone | 4件: Triamcinolone
Triamcinolone
,
Triamcinolone acetonide
,
Triamcinolone diacetate
,
Triamcinolone hexacetonide
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 6件: 46 46, 53, 90, 96, 226, 298 💬
|
| 1108 | Triangular test | - | - | - | - | 1件: 96 96 💬
|
| 1109 | Trichuris suis eggs | - | - | - | - | 3件: 13 13, 96, 97 💬
|
| 1110 | Trichuris suis OVA | - | - | - | - | 4件: 13 13, 46, 96, 97 💬
|
| 1111 | Trichuris trichiura eggs | - | - | - | - | 1件: 96 96 💬
|
| 1112 | Trilac | - | - | - | - | 2件: 96 96, 97 💬
|
| 1113 | Tripterygium glycosides | 1件: Tripterygium wilfordii whole Tripterygium wilfordii whole | - | - | - | 1件: 96 96 💬
|
| 1114 | Tris | 1件: Tromethamine Tromethamine | 1件: Tromethamine
Tromethamine
💬
| - | - | 2件: 96 96, 97 💬
|
| 1115 | TRK-170 | - | - | - | - | 1件: 96 96 💬
|
| 1116 | TRX103 | - | - | - | - | 1件: 96 96 💬
|
| 1117 | Trypsin | 1件: Trypsin Trypsin | 1件: Trypsin, crystallized
Trypsin, crystallized
💬
| - | - | 1件: 96 96 💬
|
| 1118 | TSO 250 | - | - | - | - | 1件: 96 96 💬
|
| 1119 | TSO 2500 | - | - | - | - | 1件: 96 96 💬
|
| 1120 | TSO 7500 | - | - | - | - | 1件: 96 96 💬
|
| 1121 | TU-100 | 1件: TU-100 TU-100 | - | - | - | 1件: 96 96 💬
|
| 1122 | Tulisokibart | 1件: Tulisokibart Tulisokibart | 1件: Tulisokibart
Tulisokibart
💬
| 1件: TNFSF15 TNFSF15 💬
| 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 3件: 51 51, 96, 97 💬
|
| 1123 | TV-5600 | - | - | - | - | 3件: 8 8, 13, 96 💬
|
| 1124 | UC-mscs BY peripheral intravenous infusion | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 96 96 💬
|
| 1125 | Ultrasound elastography | - | - | - | - | 1件: 96 96 💬
|
| 1126 | Ultrasound imaging | - | - | - | - | 2件: 34 34, 96 💬
|
| 1127 | Ultrasound microbubble contrast agent | - | - | - | - | 1件: 96 96 💬
|
| 1128 | Ultrasound vascularity | - | - | - | - | 1件: 96 96 💬
|
| 1129 | Undetermined | - | - | - | - | 2件: 96 96, 97 💬
|
| 1130 | Upadacitinib | 1件: Upadacitinib Upadacitinib | 3件: Upadacitinib
Upadacitinib
,
Upadacitinib tartrate
,
Upadacitinib hydrate
💬
| 1件: JAK1 JAK1 💬
| 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 10件: 40 40, 41, 46, 49, 53, 55, 96, 97, 107, 271 💬
|
| 1131 | Upadaticitib | - | - | - | - | 1件: 96 96 💬
|
| 1132 | Ursodeoxycholic acid | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: Ursodiol
Ursodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 8件: 6 6, 67, 84, 93, 94, 95, 96, 97 💬
|
| 1133 | Ursofalk | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: Ursodiol
Ursodiol
💬
| 1件: NR1H4 NR1H4 💬
| 1件: Bile secretion Bile secretion 💬 | 4件: 93 93, 94, 96, 97 💬
|
| 1134 | US TAP bupivacaine/epinephrine | - | - | - | - | 2件: 96 96, 97 💬
|
| 1135 | Ustekinumab | 1件: Ustekinumab |